{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "6d2ce2cf-e139-4045-b6b3-802ddfd248c6",
   "metadata": {},
   "source": [
    "# Predicting Clinical Trial Terminations\n",
    "### Notebook 2: Preprocessing & EDA\n",
    "\n",
    "**Author: Clement Chan**\n",
    "\n",
    "---\n",
    "Notes on the notebook:\n",
    "- The previous notebook consists of the raw dataset and the steps involved in cleaning. We also performed preliminary EDA and highlighted the distribution of important columns and analyzed what potential features we should include in the model.\n",
    "- In this notebook, we will complete a second round of more in-depth cleaning and exploratory data analysis. Our goal is to create a baseline model for statistical analysis, prepare for feature engineering and modelling."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0d81d7bc-34ce-4d8b-b87b-db5f478575c9",
   "metadata": {},
   "source": [
    "### Data Dictionary for this notebook that is based on clinicaltrials.gov:\n",
    "\n",
    "---\n",
    "\n",
    "| Column | Description                                  |Data Type|\n",
    "|-------|--------------------------------------------|-------|\n",
    "| Study Title | Title of the Clinical Trial           | object |\n",
    "| Study Status | Binary column, 0 for Completed Trials and 1 for Terminated Trials | int |\n",
    "| Brief Summary | Short description of the clinical study (Includes study hypothesis) | object |\n",
    "| Study Results | Whether the results are posted (yes = 1 or no = 0) | int|\n",
    "| Conditions | Primary Disease or Condition being studied     | object |\n",
    "| Interventions | The methods used in the trial to reach the outcome                 | object |\n",
    "| Primary Outcome Measures | Description of specific primary outcome | object |\n",
    "| Secondary Outcome Measures | Description of specific secondary outcome | object |\n",
    "| Sponsor | The corporation or agency that initiates the study | object |\n",
    "| Collaborators | Other organizations that provide support | object |\n",
    "| Sex | All: No limit on eligibility based on sex, Male: Only male participants, Female: Only female participants | int |\n",
    "| Age | Age group of participants: ADULT, OLDER_ADULT, CHILD  | int |\n",
    "| Phases | Clinical trial phase of the study (drug)... need to classify this futher. | object (dummies?)|\n",
    "| Enrollment | Total estimated number of participants in a study or total actual enrollment? | float -> int |\n",
    "| Funder Type | Funding type in category? | object (could classify into dummies) |\n",
    "| Study Type | Interventional, Observational, or Expanded Access | object (definitely dummies) |\n",
    "| Study Design | Study design based on study type | object |\n",
    "| Start Date | Estimated/Actual date the first participant was enrolled | object -> date |\n",
    "| Primary Completion Date | Date the final participant was examined for the first outcome | object -> date |\n",
    "| Completion Date | Date the final participant was examined | object -> date |\n",
    "| First Posted | Date the clinical trial was first posted to the public      | object -> date  |\n",
    "| Last Update Posted | Date the clinical trial was last posted to the public   | object -> date |\n",
    "| Locations | Where the clinical study will be held | object |"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b0a868a4-251d-4f72-9d69-c3361ca34940",
   "metadata": {},
   "source": [
    "**Importing Libraries**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "1e667164-1ed8-4b86-ba4c-d6c789bb66dc",
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7f2c52a1-790f-4f49-a1ff-c7690b39f400",
   "metadata": {},
   "source": [
    "<a id = 'toc'><a/>\n",
    "## Table of Contents\n",
    "\n",
    "---\n",
    "1. [Data Preprocessing](#prep)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ddd3bf0e-f487-4b29-a055-651ead069a58",
   "metadata": {},
   "source": [
    "**Load the dataset**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "0b9df7e6-a323-49c7-a0d4-413cb951e791",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>...</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Effectiveness of a Problem-solving Interventio...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>We will conduct a two-arm individually randomi...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Mental Health Issue (E.G., Depression, Psychos...</td>\n",
       "      <td>behavioral: pride 'step 1' problem-solving int...</td>\n",
       "      <td>Mental health symptoms, The Strengths and Diff...</td>\n",
       "      <td>Mental health symptoms, The adolescent-reporte...</td>\n",
       "      <td>Sangath</td>\n",
       "      <td>Harvard Medical School (HMS and HSDM)|London S...</td>\n",
       "      <td>...</td>\n",
       "      <td>250</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2018-08-20</td>\n",
       "      <td>2019-01-20</td>\n",
       "      <td>2019-02-28</td>\n",
       "      <td>2018-08-14</td>\n",
       "      <td>2019-05-21</td>\n",
       "      <td>Sangath, New Delhi, Delhi, 110016, India</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Oral Ketone Monoester Supplementation and Rest...</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>People who report subjective memory complaints...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cerebrovascular Function|Cognition</td>\n",
       "      <td>other: placebo|dietary_supplement: Î²-ohb</td>\n",
       "      <td>Brain network connectivity, Functional connect...</td>\n",
       "      <td>Working memory, Computer battery to assess wor...</td>\n",
       "      <td>McMaster University</td>\n",
       "      <td>Alzheimer's Society of Brant, Haldimand Norfol...</td>\n",
       "      <td>...</td>\n",
       "      <td>30</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>2023-10-25</td>\n",
       "      <td>2024-08</td>\n",
       "      <td>2024-08</td>\n",
       "      <td>2023-08-15</td>\n",
       "      <td>2023-12-01</td>\n",
       "      <td>McMaster University, Hamilton, Ontario, L8S 4K...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Investigating the Effect of a Prenatal Family ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The purpose of this study is to measure the di...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Focus: Contraceptive Counseling|Focus: Postpar...</td>\n",
       "      <td>other: family planning counseling let by commu...</td>\n",
       "      <td>Self-reported contraceptive use, 6 months post...</td>\n",
       "      <td>Intent to use contraception in the future, 6 m...</td>\n",
       "      <td>Planned Parenthood League of Massachusetts</td>\n",
       "      <td>Society for Family Planning Research Fund</td>\n",
       "      <td>...</td>\n",
       "      <td>176</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2013-08</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2013-05-15</td>\n",
       "      <td>2015-08-17</td>\n",
       "      <td>Palestinian Ministry of Health Maternal Child ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Pre-exposure Prophylaxis (PrEP) for People Who...</td>\n",
       "      <td>WITHDRAWN</td>\n",
       "      <td>People who inject drugs (PWID) experience high...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Intravenous Drug Abuse</td>\n",
       "      <td>behavioral: prep uptake/adherence intervention...</td>\n",
       "      <td>PrEP uptake by self-report, measured using 1 i...</td>\n",
       "      <td>Participant satisfaction with intervention con...</td>\n",
       "      <td>Boston University</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA)</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2021-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2019-03-11</td>\n",
       "      <td>2021-03-10</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Tailored Inhibitory Control Training to Revers...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Insufficient inhibitory control is one pathway...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Smoking|Alcohol Drinking|Prescription Drug Abu...</td>\n",
       "      <td>behavioral: person-centered inhibitory control...</td>\n",
       "      <td>Inhibitory control performance, Task 1, Perfor...</td>\n",
       "      <td>Far transfer to a task related to inhibitory c...</td>\n",
       "      <td>University of Oregon</td>\n",
       "      <td>none</td>\n",
       "      <td>...</td>\n",
       "      <td>103</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2014-09</td>\n",
       "      <td>2016-04</td>\n",
       "      <td>2016-05</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>University of Oregon, Social and Affective Neu...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows Ã 23 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                         Study Title Study Status  \\\n",
       "0  Effectiveness of a Problem-solving Interventio...    COMPLETED   \n",
       "1  Oral Ketone Monoester Supplementation and Rest...   RECRUITING   \n",
       "2  Investigating the Effect of a Prenatal Family ...    COMPLETED   \n",
       "3  Pre-exposure Prophylaxis (PrEP) for People Who...    WITHDRAWN   \n",
       "4  Tailored Inhibitory Control Training to Revers...    COMPLETED   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  We will conduct a two-arm individually randomi...            NO   \n",
       "1  People who report subjective memory complaints...            NO   \n",
       "2  The purpose of this study is to measure the di...            NO   \n",
       "3  People who inject drugs (PWID) experience high...            NO   \n",
       "4  Insufficient inhibitory control is one pathway...            NO   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0  Mental Health Issue (E.G., Depression, Psychos...   \n",
       "1                 Cerebrovascular Function|Cognition   \n",
       "2  Focus: Contraceptive Counseling|Focus: Postpar...   \n",
       "3                             Intravenous Drug Abuse   \n",
       "4  Smoking|Alcohol Drinking|Prescription Drug Abu...   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  behavioral: pride 'step 1' problem-solving int...   \n",
       "1           other: placebo|dietary_supplement: Î²-ohb   \n",
       "2  other: family planning counseling let by commu...   \n",
       "3  behavioral: prep uptake/adherence intervention...   \n",
       "4  behavioral: person-centered inhibitory control...   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Mental health symptoms, The Strengths and Diff...   \n",
       "1  Brain network connectivity, Functional connect...   \n",
       "2  Self-reported contraceptive use, 6 months post...   \n",
       "3  PrEP uptake by self-report, measured using 1 i...   \n",
       "4  Inhibitory control performance, Task 1, Perfor...   \n",
       "\n",
       "                          Secondary Outcome Measures  \\\n",
       "0  Mental health symptoms, The adolescent-reporte...   \n",
       "1  Working memory, Computer battery to assess wor...   \n",
       "2  Intent to use contraception in the future, 6 m...   \n",
       "3  Participant satisfaction with intervention con...   \n",
       "4  Far transfer to a task related to inhibitory c...   \n",
       "\n",
       "                                      Sponsor  \\\n",
       "0                                     Sangath   \n",
       "1                         McMaster University   \n",
       "2  Planned Parenthood League of Massachusetts   \n",
       "3                           Boston University   \n",
       "4                        University of Oregon   \n",
       "\n",
       "                                       Collaborators  ... Enrollment  \\\n",
       "0  Harvard Medical School (HMS and HSDM)|London S...  ...        250   \n",
       "1  Alzheimer's Society of Brant, Haldimand Norfol...  ...         30   \n",
       "2          Society for Family Planning Research Fund  ...        176   \n",
       "3            National Institute on Drug Abuse (NIDA)  ...          0   \n",
       "4                                               none  ...        103   \n",
       "\n",
       "  Funder Type      Study Type  \\\n",
       "0       OTHER  INTERVENTIONAL   \n",
       "1       OTHER  INTERVENTIONAL   \n",
       "2       OTHER  INTERVENTIONAL   \n",
       "3       OTHER  INTERVENTIONAL   \n",
       "4       OTHER  INTERVENTIONAL   \n",
       "\n",
       "                                        Study Design  Start Date  \\\n",
       "0  Allocation: RANDOMIZED|Intervention Model: PAR...  2018-08-20   \n",
       "1  Allocation: RANDOMIZED|Intervention Model: CRO...  2023-10-25   \n",
       "2  Allocation: NON_RANDOMIZED|Intervention Model:...     2013-08   \n",
       "3  Allocation: RANDOMIZED|Intervention Model: PAR...     2021-03   \n",
       "4  Allocation: RANDOMIZED|Intervention Model: PAR...     2014-09   \n",
       "\n",
       "  Primary Completion Date Completion Date First Posted Last Update Posted  \\\n",
       "0              2019-01-20      2019-02-28   2018-08-14         2019-05-21   \n",
       "1                 2024-08         2024-08   2023-08-15         2023-12-01   \n",
       "2                 2014-12         2014-12   2013-05-15         2015-08-17   \n",
       "3                 2022-03         2022-03   2019-03-11         2021-03-10   \n",
       "4                 2016-04         2016-05   2016-10-26         2016-10-26   \n",
       "\n",
       "                                           Locations  \n",
       "0           Sangath, New Delhi, Delhi, 110016, India  \n",
       "1  McMaster University, Hamilton, Ontario, L8S 4K...  \n",
       "2  Palestinian Ministry of Health Maternal Child ...  \n",
       "3                                            unknown  \n",
       "4  University of Oregon, Social and Affective Neu...  \n",
       "\n",
       "[5 rows x 23 columns]"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# make sure to not include the index_col\n",
    "df = pd.read_csv('updated_ctg.csv', index_col = 0)\n",
    "\n",
    "# First 5 rows of dataset\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9b896ad3-9252-4ec5-a8bc-602db9eb6c0b",
   "metadata": {},
   "source": [
    "Let's find the total number of rows and columns in the data."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "0fd25472-a13e-4665-a7f2-5405e9b02169",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The dataset has 482350 rows and 23 columns.\n"
     ]
    }
   ],
   "source": [
    "print(f'The dataset has {df.shape[0]} rows and {df.shape[1]} columns.')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d508b7ad-f18f-4d52-b2fc-8355cd647024",
   "metadata": {},
   "source": [
    "Check the information of the dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "8da5d301-ffba-4b80-9189-f8b51a938d21",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Index: 482350 entries, 0 to 482349\n",
      "Data columns (total 23 columns):\n",
      " #   Column                      Non-Null Count   Dtype \n",
      "---  ------                      --------------   ----- \n",
      " 0   Study Title                 482350 non-null  object\n",
      " 1   Study Status                482350 non-null  object\n",
      " 2   Brief Summary               482350 non-null  object\n",
      " 3   Study Results               482350 non-null  object\n",
      " 4   Conditions                  482350 non-null  object\n",
      " 5   Interventions               482350 non-null  object\n",
      " 6   Primary Outcome Measures    482350 non-null  object\n",
      " 7   Secondary Outcome Measures  482350 non-null  object\n",
      " 8   Sponsor                     482350 non-null  object\n",
      " 9   Collaborators               482350 non-null  object\n",
      " 10  Sex                         482350 non-null  object\n",
      " 11  Age                         482350 non-null  object\n",
      " 12  Phases                      482350 non-null  object\n",
      " 13  Enrollment                  482350 non-null  int64 \n",
      " 14  Funder Type                 482350 non-null  object\n",
      " 15  Study Type                  482350 non-null  object\n",
      " 16  Study Design                482350 non-null  object\n",
      " 17  Start Date                  482350 non-null  object\n",
      " 18  Primary Completion Date     482350 non-null  object\n",
      " 19  Completion Date             482350 non-null  object\n",
      " 20  First Posted                482350 non-null  object\n",
      " 21  Last Update Posted          482350 non-null  object\n",
      " 22  Locations                   482350 non-null  object\n",
      "dtypes: int64(1), object(22)\n",
      "memory usage: 88.3+ MB\n"
     ]
    }
   ],
   "source": [
    "df.info()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bba39713-6f74-4778-8ceb-c53f3a70662e",
   "metadata": {},
   "source": [
    "In the previous notebook, our approach was to drop columns that contain a large amount of missing values, and impute them with the string 'unknown', 'missing', and 'none'. Now, we will target specific columns that seem to have a big impact or significance in determining the `Study Status` variable.\n",
    "\n",
    "Since the `Study Status` column is our main dependent variable that we are predicting. Let's explore the distribution again, and see if we can minimize the amount of unique values or categories.\n",
    "- Start by looking at the value counts\n",
    "- Visualize the distribution of the categories\n",
    "- Group common categories or remove categories that are insignificant to the model."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "8cf48322-3535-43ef-a1ee-515f6151404a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                    263380\n",
       "RECRUITING                    66150\n",
       "UNKNOWN                       64828\n",
       "TERMINATED                    28014\n",
       "NOT_YET_RECRUITING            20055\n",
       "ACTIVE_NOT_RECRUITING         19702\n",
       "WITHDRAWN                     13716\n",
       "ENROLLING_BY_INVITATION        3931\n",
       "SUSPENDED                      1646\n",
       "NO_LONGER_AVAILABLE             446\n",
       "AVAILABLE                       259\n",
       "APPROVED_FOR_MARKETING          197\n",
       "TEMPORARILY_NOT_AVAILABLE        26\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "c089256a-7934-4a9a-ae1a-b8c4a15befc9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Visualize counts with a graph\n",
    "plt.figure()\n",
    "\n",
    "df['Study Status'].value_counts().plot(kind='barh')\n",
    "\n",
    "plt.title('Number of Studies in Each study status'.title())\n",
    "plt.ylabel('Study Status')\n",
    "plt.xlabel('Number of Studies')\n",
    "\n",
    "sns.despine()\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ff44ac73-1c66-4f59-971a-b4a13e79e00f",
   "metadata": {},
   "source": [
    "Most of the studies have been completed, which can cause some data imbalance in other classes such as our targeted 'Terminated' category. Let's continue with the cleaning, and see where we can group common categories together starting with the lowest counts `TEMPORARILY_NOT_AVAILABLE`."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "0295de14-bbe5-4e21-9e6d-dc5ffc3a42e1",
   "metadata": {},
   "outputs": [],
   "source": [
    "# this option displays all columns in the dataframe\n",
    "pd.options.display.max_columns = None"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "9e637507-a8c0-4d31-a590-8a173f240565",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>11239</th>\n",
       "      <td>Thrombosomes for Expanded Access Use</td>\n",
       "      <td>TEMPORARILY_NOT_AVAILABLE</td>\n",
       "      <td>Expanded use of Thrombosomes where a clinical ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Bleeding</td>\n",
       "      <td>biological: thrombosomesÂ®</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Cellphire Therapeutics, Inc.</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2020-11-06</td>\n",
       "      <td>2022-01-28</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47190</th>\n",
       "      <td>A Phase I Clinical Study of the Safety, Tolera...</td>\n",
       "      <td>TEMPORARILY_NOT_AVAILABLE</td>\n",
       "      <td>This study is designed to multiple dose and do...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Healthy</td>\n",
       "      <td>drug: hx-1171</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Biotoxtech Co., Ltd</td>\n",
       "      <td>none</td>\n",
       "      <td>MALE</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2013-06-28</td>\n",
       "      <td>2013-06-28</td>\n",
       "      <td>Asan Medical Center, Special City of Seoul, Ko...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53091</th>\n",
       "      <td>Treating Amyotrophic Lateral Sclerosis (ALS) W...</td>\n",
       "      <td>TEMPORARILY_NOT_AVAILABLE</td>\n",
       "      <td>R(+) pramipexole dihydrochloride monohydrate \\...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Amyotrophic Lateral Sclerosis</td>\n",
       "      <td>drug: r(+) pramipexole dihydrochloride monohyd...</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Bennett, James P., Jr., M.D., Ph.D.</td>\n",
       "      <td>University of Pittsburgh|University of Nebraska</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDIV</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2008-01-16</td>\n",
       "      <td>2012-07-25</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53366</th>\n",
       "      <td>Development of a Fall Prevention and Fall Dete...</td>\n",
       "      <td>TEMPORARILY_NOT_AVAILABLE</td>\n",
       "      <td>The investigators plan to conduct a first-stag...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Parkinson's Disease</td>\n",
       "      <td>other: portable motion detector</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Far Eastern Memorial Hospital</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2010-12-20</td>\n",
       "      <td>2010-12-20</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>104237</th>\n",
       "      <td>Post-trial Access for Nipocalimab in Participa...</td>\n",
       "      <td>TEMPORARILY_NOT_AVAILABLE</td>\n",
       "      <td>The purpose of this post-trial access (PTA) pr...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Warm Autoimmune Hemolytic Anemia</td>\n",
       "      <td>drug: nipocalimab</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Janssen Research &amp; Development, LLC</td>\n",
       "      <td>none</td>\n",
       "      <td>unknown</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2022-02-03</td>\n",
       "      <td>2024-01-23</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              Study Title  \\\n",
       "11239                Thrombosomes for Expanded Access Use   \n",
       "47190   A Phase I Clinical Study of the Safety, Tolera...   \n",
       "53091   Treating Amyotrophic Lateral Sclerosis (ALS) W...   \n",
       "53366   Development of a Fall Prevention and Fall Dete...   \n",
       "104237  Post-trial Access for Nipocalimab in Participa...   \n",
       "\n",
       "                     Study Status  \\\n",
       "11239   TEMPORARILY_NOT_AVAILABLE   \n",
       "47190   TEMPORARILY_NOT_AVAILABLE   \n",
       "53091   TEMPORARILY_NOT_AVAILABLE   \n",
       "53366   TEMPORARILY_NOT_AVAILABLE   \n",
       "104237  TEMPORARILY_NOT_AVAILABLE   \n",
       "\n",
       "                                            Brief Summary Study Results  \\\n",
       "11239   Expanded use of Thrombosomes where a clinical ...            NO   \n",
       "47190   This study is designed to multiple dose and do...            NO   \n",
       "53091   R(+) pramipexole dihydrochloride monohydrate \\...            NO   \n",
       "53366   The investigators plan to conduct a first-stag...            NO   \n",
       "104237  The purpose of this post-trial access (PTA) pr...            NO   \n",
       "\n",
       "                              Conditions  \\\n",
       "11239                           Bleeding   \n",
       "47190                            Healthy   \n",
       "53091      Amyotrophic Lateral Sclerosis   \n",
       "53366                Parkinson's Disease   \n",
       "104237  Warm Autoimmune Hemolytic Anemia   \n",
       "\n",
       "                                            Interventions  \\\n",
       "11239                           biological: thrombosomesÂ®   \n",
       "47190                                       drug: hx-1171   \n",
       "53091   drug: r(+) pramipexole dihydrochloride monohyd...   \n",
       "53366                     other: portable motion detector   \n",
       "104237                                  drug: nipocalimab   \n",
       "\n",
       "       Primary Outcome Measures Secondary Outcome Measures  \\\n",
       "11239                   unknown                       none   \n",
       "47190                   unknown                       none   \n",
       "53091                   unknown                       none   \n",
       "53366                   unknown                       none   \n",
       "104237                  unknown                       none   \n",
       "\n",
       "                                    Sponsor  \\\n",
       "11239          Cellphire Therapeutics, Inc.   \n",
       "47190                   Biotoxtech Co., Ltd   \n",
       "53091   Bennett, James P., Jr., M.D., Ph.D.   \n",
       "53366         Far Eastern Memorial Hospital   \n",
       "104237  Janssen Research & Development, LLC   \n",
       "\n",
       "                                          Collaborators      Sex  \\\n",
       "11239                                              none      ALL   \n",
       "47190                                              none     MALE   \n",
       "53091   University of Pittsburgh|University of Nebraska      ALL   \n",
       "53366                                              none      ALL   \n",
       "104237                                             none  unknown   \n",
       "\n",
       "                              Age    Phases  Enrollment Funder Type  \\\n",
       "11239          ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY   \n",
       "47190                       ADULT  NO PHASE          69    INDUSTRY   \n",
       "53091          ADULT, OLDER_ADULT  NO PHASE          69       INDIV   \n",
       "53366   CHILD, ADULT, OLDER_ADULT  NO PHASE          69       OTHER   \n",
       "104237  CHILD, ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY   \n",
       "\n",
       "             Study Type Study Design Start Date Primary Completion Date  \\\n",
       "11239   EXPANDED_ACCESS      unknown    unknown                 unknown   \n",
       "47190   EXPANDED_ACCESS      unknown    unknown                 unknown   \n",
       "53091   EXPANDED_ACCESS      unknown    unknown                 unknown   \n",
       "53366   EXPANDED_ACCESS      unknown    unknown                 unknown   \n",
       "104237  EXPANDED_ACCESS      unknown    unknown                 unknown   \n",
       "\n",
       "       Completion Date First Posted Last Update Posted  \\\n",
       "11239          unknown   2020-11-06         2022-01-28   \n",
       "47190          unknown   2013-06-28         2013-06-28   \n",
       "53091          unknown   2008-01-16         2012-07-25   \n",
       "53366          unknown   2010-12-20         2010-12-20   \n",
       "104237         unknown   2022-02-03         2024-01-23   \n",
       "\n",
       "                                                Locations  \n",
       "11239                                             unknown  \n",
       "47190   Asan Medical Center, Special City of Seoul, Ko...  \n",
       "53091                                             unknown  \n",
       "53366                                             unknown  \n",
       "104237                                            unknown  "
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# slice out rows where study status is TEMPORARILY_NOT_AVAILABLE\n",
    "df[df['Study Status'] == 'TEMPORARILY_NOT_AVAILABLE'].head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6e82c4a6-e3f3-4f37-9d7b-b2a0acd78afb",
   "metadata": {},
   "source": [
    "We can see that the rows where **(Study Status = Temporarily_not_available)** are missing a lot of information in the columns `Outcome_measures`, `Collaborators`, `Study Design`, and some `Locations`. Since this study status is neither completed or terminated, it doesn't provide any meaningful information to the model and we should remove these rows from the dataset."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "d3c80ef3-5086-4615-b3d0-244804094b0b",
   "metadata": {},
   "outputs": [],
   "source": [
    "# drop rows where study status = temp_not_available\n",
    "df.drop(index = df[df['Study Status'] == 'TEMPORARILY_NOT_AVAILABLE'].index, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "5926c856-5111-4d8d-8dde-95b13ed3b0d6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                  263380\n",
       "RECRUITING                  66150\n",
       "UNKNOWN                     64828\n",
       "TERMINATED                  28014\n",
       "NOT_YET_RECRUITING          20055\n",
       "ACTIVE_NOT_RECRUITING       19702\n",
       "WITHDRAWN                   13716\n",
       "ENROLLING_BY_INVITATION      3931\n",
       "SUSPENDED                    1646\n",
       "NO_LONGER_AVAILABLE           446\n",
       "AVAILABLE                     259\n",
       "APPROVED_FOR_MARKETING        197\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2478d340-5bde-4cb1-8670-d13e3fffef37",
   "metadata": {},
   "source": [
    "Next we should look at `APPROVED_FOR_MARKETING` status, and see where we can group those."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "d506a6db-d46b-4fe7-8ebd-af344d6f65a8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>8036</th>\n",
       "      <td>Expanded Access of Pimavanserin for Patients W...</td>\n",
       "      <td>APPROVED_FOR_MARKETING</td>\n",
       "      <td>The purpose of this program is to provide pati...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Parkinson's Disease Psychosis</td>\n",
       "      <td>drug: pimavanserin tartrate</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>ACADIA Pharmaceuticals Inc.</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2016-05-05</td>\n",
       "      <td>2017-04-18</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8345</th>\n",
       "      <td>18F-FDG PET Imaging in Cardiac Sarcoidosis</td>\n",
       "      <td>APPROVED_FOR_MARKETING</td>\n",
       "      <td>This study has been designed to provide patien...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiac Sarcoidosis</td>\n",
       "      <td>other: 18f-fluorodeoxyglucose (18f-fdg) pet/ct</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>British Columbia Cancer Agency</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2013-01-09</td>\n",
       "      <td>2022-02-04</td>\n",
       "      <td>BC Cancer Agency, Vancouver, British Columbia,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8886</th>\n",
       "      <td>Early Access Treatment With Daratumumab for (R...</td>\n",
       "      <td>APPROVED_FOR_MARKETING</td>\n",
       "      <td>The objective of this study is to provide earl...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Multiple Myeloma</td>\n",
       "      <td>drug: daratumumab</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Janssen Research &amp; Development, LLC</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2015-06-23</td>\n",
       "      <td>2019-01-15</td>\n",
       "      <td>Phoenix, Arizona, United States|Little Rock, A...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10306</th>\n",
       "      <td>An Expanded Access Treatment Protocol of Enfor...</td>\n",
       "      <td>APPROVED_FOR_MARKETING</td>\n",
       "      <td>The primary purpose of this expanded access pr...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Locally Advanced or Metastatic Urothelial Carc...</td>\n",
       "      <td>drug: enfortumab vedotin (ev)</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Astellas Pharma Global Development, Inc.</td>\n",
       "      <td>Seagen Inc.</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2019-10-23</td>\n",
       "      <td>2020-01-13</td>\n",
       "      <td>UCLA Hematology Oncology, Los Angeles, Califor...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11729</th>\n",
       "      <td>An Expanded Access Study to Provide at Home Su...</td>\n",
       "      <td>APPROVED_FOR_MARKETING</td>\n",
       "      <td>This single arm, multicenter study provides th...</td>\n",
       "      <td>NO</td>\n",
       "      <td>HER2-positive Breast Cancer</td>\n",
       "      <td>drug: pertuzumab and trastuzumab fixed-dose co...</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Genentech, Inc.</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2020-05-20</td>\n",
       "      <td>2022-07-05</td>\n",
       "      <td>Beverly Hills Cancer Center, Beverly Hills, Ca...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                             Study Title  \\\n",
       "8036   Expanded Access of Pimavanserin for Patients W...   \n",
       "8345          18F-FDG PET Imaging in Cardiac Sarcoidosis   \n",
       "8886   Early Access Treatment With Daratumumab for (R...   \n",
       "10306  An Expanded Access Treatment Protocol of Enfor...   \n",
       "11729  An Expanded Access Study to Provide at Home Su...   \n",
       "\n",
       "                 Study Status  \\\n",
       "8036   APPROVED_FOR_MARKETING   \n",
       "8345   APPROVED_FOR_MARKETING   \n",
       "8886   APPROVED_FOR_MARKETING   \n",
       "10306  APPROVED_FOR_MARKETING   \n",
       "11729  APPROVED_FOR_MARKETING   \n",
       "\n",
       "                                           Brief Summary Study Results  \\\n",
       "8036   The purpose of this program is to provide pati...            NO   \n",
       "8345   This study has been designed to provide patien...            NO   \n",
       "8886   The objective of this study is to provide earl...            NO   \n",
       "10306  The primary purpose of this expanded access pr...            NO   \n",
       "11729  This single arm, multicenter study provides th...            NO   \n",
       "\n",
       "                                              Conditions  \\\n",
       "8036                       Parkinson's Disease Psychosis   \n",
       "8345                                 Cardiac Sarcoidosis   \n",
       "8886                                    Multiple Myeloma   \n",
       "10306  Locally Advanced or Metastatic Urothelial Carc...   \n",
       "11729                        HER2-positive Breast Cancer   \n",
       "\n",
       "                                           Interventions  \\\n",
       "8036                         drug: pimavanserin tartrate   \n",
       "8345      other: 18f-fluorodeoxyglucose (18f-fdg) pet/ct   \n",
       "8886                                   drug: daratumumab   \n",
       "10306                      drug: enfortumab vedotin (ev)   \n",
       "11729  drug: pertuzumab and trastuzumab fixed-dose co...   \n",
       "\n",
       "      Primary Outcome Measures Secondary Outcome Measures  \\\n",
       "8036                   unknown                       none   \n",
       "8345                   unknown                       none   \n",
       "8886                   unknown                       none   \n",
       "10306                  unknown                       none   \n",
       "11729                  unknown                       none   \n",
       "\n",
       "                                        Sponsor Collaborators  Sex  \\\n",
       "8036                ACADIA Pharmaceuticals Inc.          none  ALL   \n",
       "8345             British Columbia Cancer Agency          none  ALL   \n",
       "8886        Janssen Research & Development, LLC          none  ALL   \n",
       "10306  Astellas Pharma Global Development, Inc.   Seagen Inc.  ALL   \n",
       "11729                           Genentech, Inc.          none  ALL   \n",
       "\n",
       "                      Age    Phases  Enrollment Funder Type       Study Type  \\\n",
       "8036   ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS   \n",
       "8345   ADULT, OLDER_ADULT  NO PHASE          69       OTHER  EXPANDED_ACCESS   \n",
       "8886   ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS   \n",
       "10306  ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS   \n",
       "11729  ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS   \n",
       "\n",
       "      Study Design Start Date Primary Completion Date Completion Date  \\\n",
       "8036       unknown    unknown                 unknown         unknown   \n",
       "8345       unknown    unknown                 unknown         unknown   \n",
       "8886       unknown    unknown                 unknown         unknown   \n",
       "10306      unknown    unknown                 unknown         unknown   \n",
       "11729      unknown    unknown                 unknown         unknown   \n",
       "\n",
       "      First Posted Last Update Posted  \\\n",
       "8036    2016-05-05         2017-04-18   \n",
       "8345    2013-01-09         2022-02-04   \n",
       "8886    2015-06-23         2019-01-15   \n",
       "10306   2019-10-23         2020-01-13   \n",
       "11729   2020-05-20         2022-07-05   \n",
       "\n",
       "                                               Locations  \n",
       "8036                                             unknown  \n",
       "8345   BC Cancer Agency, Vancouver, British Columbia,...  \n",
       "8886   Phoenix, Arizona, United States|Little Rock, A...  \n",
       "10306  UCLA Hematology Oncology, Los Angeles, Califor...  \n",
       "11729  Beverly Hills Cancer Center, Beverly Hills, Ca...  "
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['Study Status'] == 'APPROVED_FOR_MARKETING'].head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3431ae3a-277e-44fa-912d-6b12615a4aee",
   "metadata": {},
   "source": [
    "Simiar to the temp_not_available, the category `APPROVED_FOR_MARKETING` is missing a lot of information in the same categories and do not provide much insight into completed or terminated trials. We can drop these rows as well."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "ad4331cb-f0b4-4c4d-aea9-cd8d8fbaaeba",
   "metadata": {},
   "outputs": [],
   "source": [
    "# drop rows where study status = APPROVED_FOR_MARKETING\n",
    "df.drop(index = df[df['Study Status'] == 'APPROVED_FOR_MARKETING'].index, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "7e286b2d-a254-48eb-b522-ba06d07f2659",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                  263380\n",
       "RECRUITING                  66150\n",
       "UNKNOWN                     64828\n",
       "TERMINATED                  28014\n",
       "NOT_YET_RECRUITING          20055\n",
       "ACTIVE_NOT_RECRUITING       19702\n",
       "WITHDRAWN                   13716\n",
       "ENROLLING_BY_INVITATION      3931\n",
       "SUSPENDED                    1646\n",
       "NO_LONGER_AVAILABLE           446\n",
       "AVAILABLE                     259\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4abf9caa-82b8-4d55-a873-497b1e9fb074",
   "metadata": {},
   "source": [
    "Now, we will look into the `AVAILABLE` category to see where we can group those."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "6b969b46-b334-483b-bfac-23a40dd6f227",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1049</th>\n",
       "      <td>Expanded Access to Ensartinib for Participants...</td>\n",
       "      <td>AVAILABLE</td>\n",
       "      <td>This is an open-label, multicenter, intermedia...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Non-Small Cell Lung Cancer|ALK Gene Rearrangem...</td>\n",
       "      <td>drug: ensartinib</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Xcovery Holdings, Inc.</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2019-10-31</td>\n",
       "      <td>2022-10-20</td>\n",
       "      <td>Stanford University, Stanford, California, 943...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2621</th>\n",
       "      <td>Intermediate-size Expanded Access Program (EAP...</td>\n",
       "      <td>AVAILABLE</td>\n",
       "      <td>The objectives of this intermediate-size expan...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Multisystem Inflammatory Syndrome in Children ...</td>\n",
       "      <td>biological: remestemcel-l|drug: hydrocortisone...</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Mesoblast International SÃ rl</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2020-07-02</td>\n",
       "      <td>2023-05-06</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3931</th>\n",
       "      <td>Chronic Effect of Mat Pilates on Neuromotor, C...</td>\n",
       "      <td>AVAILABLE</td>\n",
       "      <td>The Pilates method aims to develop conscious c...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Stroke|High Blood Pressure</td>\n",
       "      <td>other: mat pilates</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Rio de Janeiro State University</td>\n",
       "      <td>Postgraduate scholarship</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2024-02-05</td>\n",
       "      <td>2024-02-14</td>\n",
       "      <td>Jeferson Silva da Rocha, Rio De Janeiro, 20550...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6425</th>\n",
       "      <td>Chelated Oral Iron Versus Intravenous Iron Suc...</td>\n",
       "      <td>AVAILABLE</td>\n",
       "      <td>compare the efficacy and safety of intravenous...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Iron Deficiency Anemia of Pregnancy</td>\n",
       "      <td>drug: chelated iron|drug: iron sucrose</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Assiut University</td>\n",
       "      <td>none</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2021-12-09</td>\n",
       "      <td>2021-12-09</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7385</th>\n",
       "      <td>A Cohort IND Expanded Access Program for Suppo...</td>\n",
       "      <td>AVAILABLE</td>\n",
       "      <td>This Expanded Access Program aims to:\\n\\n1. Pr...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Uveal Melanoma</td>\n",
       "      <td>drug: tebentafusp</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Immunocore Ltd</td>\n",
       "      <td>Clinigen, Inc.</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2021-07-14</td>\n",
       "      <td>2022-01-21</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            Study Title Study Status  \\\n",
       "1049  Expanded Access to Ensartinib for Participants...    AVAILABLE   \n",
       "2621  Intermediate-size Expanded Access Program (EAP...    AVAILABLE   \n",
       "3931  Chronic Effect of Mat Pilates on Neuromotor, C...    AVAILABLE   \n",
       "6425  Chelated Oral Iron Versus Intravenous Iron Suc...    AVAILABLE   \n",
       "7385  A Cohort IND Expanded Access Program for Suppo...    AVAILABLE   \n",
       "\n",
       "                                          Brief Summary Study Results  \\\n",
       "1049  This is an open-label, multicenter, intermedia...            NO   \n",
       "2621  The objectives of this intermediate-size expan...            NO   \n",
       "3931  The Pilates method aims to develop conscious c...            NO   \n",
       "6425  compare the efficacy and safety of intravenous...            NO   \n",
       "7385  This Expanded Access Program aims to:\\n\\n1. Pr...            NO   \n",
       "\n",
       "                                             Conditions  \\\n",
       "1049  Non-Small Cell Lung Cancer|ALK Gene Rearrangem...   \n",
       "2621  Multisystem Inflammatory Syndrome in Children ...   \n",
       "3931                         Stroke|High Blood Pressure   \n",
       "6425                Iron Deficiency Anemia of Pregnancy   \n",
       "7385                                     Uveal Melanoma   \n",
       "\n",
       "                                          Interventions  \\\n",
       "1049                                   drug: ensartinib   \n",
       "2621  biological: remestemcel-l|drug: hydrocortisone...   \n",
       "3931                                 other: mat pilates   \n",
       "6425             drug: chelated iron|drug: iron sucrose   \n",
       "7385                                  drug: tebentafusp   \n",
       "\n",
       "     Primary Outcome Measures Secondary Outcome Measures  \\\n",
       "1049                  unknown                       none   \n",
       "2621                  unknown                       none   \n",
       "3931                  unknown                       none   \n",
       "6425                  unknown                       none   \n",
       "7385                  unknown                       none   \n",
       "\n",
       "                              Sponsor             Collaborators     Sex  \\\n",
       "1049           Xcovery Holdings, Inc.                      none     ALL   \n",
       "2621     Mesoblast International SÃ rl                      none     ALL   \n",
       "3931  Rio de Janeiro State University  Postgraduate scholarship     ALL   \n",
       "6425                Assiut University                      none  FEMALE   \n",
       "7385                   Immunocore Ltd            Clinigen, Inc.     ALL   \n",
       "\n",
       "                     Age    Phases  Enrollment Funder Type       Study Type  \\\n",
       "1049  ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS   \n",
       "2621               CHILD  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS   \n",
       "3931  ADULT, OLDER_ADULT  NO PHASE          69       OTHER  EXPANDED_ACCESS   \n",
       "6425  ADULT, OLDER_ADULT  NO PHASE          69       OTHER  EXPANDED_ACCESS   \n",
       "7385  ADULT, OLDER_ADULT  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS   \n",
       "\n",
       "     Study Design Start Date Primary Completion Date Completion Date  \\\n",
       "1049      unknown    unknown                 unknown         unknown   \n",
       "2621      unknown    unknown                 unknown         unknown   \n",
       "3931      unknown    unknown                 unknown         unknown   \n",
       "6425      unknown    unknown                 unknown         unknown   \n",
       "7385      unknown    unknown                 unknown         unknown   \n",
       "\n",
       "     First Posted Last Update Posted  \\\n",
       "1049   2019-10-31         2022-10-20   \n",
       "2621   2020-07-02         2023-05-06   \n",
       "3931   2024-02-05         2024-02-14   \n",
       "6425   2021-12-09         2021-12-09   \n",
       "7385   2021-07-14         2022-01-21   \n",
       "\n",
       "                                              Locations  \n",
       "1049  Stanford University, Stanford, California, 943...  \n",
       "2621                                            unknown  \n",
       "3931  Jeferson Silva da Rocha, Rio De Janeiro, 20550...  \n",
       "6425                                            unknown  \n",
       "7385                                            unknown  "
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['Study Status'] == 'AVAILABLE'].head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8dc5b63f-d0b9-4717-bdce-e2e1435eaf4e",
   "metadata": {},
   "source": [
    "These are the studies that are now available. However, this category is missing `Study Design`, some `Collaborators`, and `Outcome_measures`. These studies could still be waiting for more information to be filled in, so for now we will remove these rows as they will not affect our prediction model."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "0c0f998a-a6c7-4908-8440-cf5f7fd61b17",
   "metadata": {},
   "outputs": [],
   "source": [
    "# drop rows where study status = AVAILABLE\n",
    "df.drop(index = df[df['Study Status'] == 'AVAILABLE'].index, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "5116b7ec-fa2a-4ef6-ab1d-8939990c04fe",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                  263380\n",
       "RECRUITING                  66150\n",
       "UNKNOWN                     64828\n",
       "TERMINATED                  28014\n",
       "NOT_YET_RECRUITING          20055\n",
       "ACTIVE_NOT_RECRUITING       19702\n",
       "WITHDRAWN                   13716\n",
       "ENROLLING_BY_INVITATION      3931\n",
       "SUSPENDED                    1646\n",
       "NO_LONGER_AVAILABLE           446\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1c021259-28c2-40ae-a65f-0c5134b1fd83",
   "metadata": {},
   "source": [
    "The `NO_LONGER_AVAILABLE` status has 446 studies, let's see where we can group these."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "c8fbeb30-db67-4d3e-83b6-b6936e2a6809",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>129846</th>\n",
       "      <td>Expanded Access to T89 for Treatment Use in In...</td>\n",
       "      <td>NO_LONGER_AVAILABLE</td>\n",
       "      <td>This expanded access use program will provide ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Covid19</td>\n",
       "      <td>drug: t89 capsule</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Tasly Pharmaceuticals, Inc.</td>\n",
       "      <td>Tasly Pharmaceutical Group Co., Ltd</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2020-11-27</td>\n",
       "      <td>2023-08-08</td>\n",
       "      <td>MultiCare Health System, Tacoma, Washington, 9...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75546</th>\n",
       "      <td>Expanded Access Single Named Patient Program W...</td>\n",
       "      <td>NO_LONGER_AVAILABLE</td>\n",
       "      <td>To provide elotuzumab treatment for single-pat...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Multiple Myeloma</td>\n",
       "      <td>drug: elotuzumab</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Sundar Jagannath</td>\n",
       "      <td>Bristol-Myers Squibb</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2015-09-04</td>\n",
       "      <td>2015-09-04</td>\n",
       "      <td>Icahn School.of Medicine at Mount Sinai, New Y...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>461013</th>\n",
       "      <td>Expanded Access Use of Stiripentol in Dravet S...</td>\n",
       "      <td>NO_LONGER_AVAILABLE</td>\n",
       "      <td>This is an expanded access use of Stiripentol ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Dravet Syndrome|Epileptic Encephalopathies Ass...</td>\n",
       "      <td>drug: stiripentol</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Cook Children's Health Care System</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2014-09-12</td>\n",
       "      <td>2020-02-05</td>\n",
       "      <td>Cook Children's Medical Center, Fort Worth, Te...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>260134</th>\n",
       "      <td>An Expanded Access Study of Oral Liquid Efavir...</td>\n",
       "      <td>NO_LONGER_AVAILABLE</td>\n",
       "      <td>This study is being conducted to assess the sa...</td>\n",
       "      <td>NO</td>\n",
       "      <td>HIV Infection</td>\n",
       "      <td>drug: efavirenz</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Bristol-Myers Squibb</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2000-09</td>\n",
       "      <td>2010-12</td>\n",
       "      <td>2010-12</td>\n",
       "      <td>2005-09-13</td>\n",
       "      <td>2014-01-09</td>\n",
       "      <td>Local Institution, Phoenix, Arizona, 85016, Un...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4585</th>\n",
       "      <td>ZYESAMI (Aviptadil) Intermediate Population Ex...</td>\n",
       "      <td>NO_LONGER_AVAILABLE</td>\n",
       "      <td>Patients with Critical COVID-19 and respirator...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Critical COVID-19 With Respiratory Failure</td>\n",
       "      <td>drug: zyesami (aviptadil acetate)</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>APR Applied Pharma Research s.a.</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>69</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>EXPANDED_ACCESS</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2020-07-01</td>\n",
       "      <td>2023-02-03</td>\n",
       "      <td>Dignity Health-Mercy Gilbert Medical Center, G...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              Study Title  \\\n",
       "129846  Expanded Access to T89 for Treatment Use in In...   \n",
       "75546   Expanded Access Single Named Patient Program W...   \n",
       "461013  Expanded Access Use of Stiripentol in Dravet S...   \n",
       "260134  An Expanded Access Study of Oral Liquid Efavir...   \n",
       "4585    ZYESAMI (Aviptadil) Intermediate Population Ex...   \n",
       "\n",
       "               Study Status  \\\n",
       "129846  NO_LONGER_AVAILABLE   \n",
       "75546   NO_LONGER_AVAILABLE   \n",
       "461013  NO_LONGER_AVAILABLE   \n",
       "260134  NO_LONGER_AVAILABLE   \n",
       "4585    NO_LONGER_AVAILABLE   \n",
       "\n",
       "                                            Brief Summary Study Results  \\\n",
       "129846  This expanded access use program will provide ...            NO   \n",
       "75546   To provide elotuzumab treatment for single-pat...            NO   \n",
       "461013  This is an expanded access use of Stiripentol ...            NO   \n",
       "260134  This study is being conducted to assess the sa...            NO   \n",
       "4585    Patients with Critical COVID-19 and respirator...            NO   \n",
       "\n",
       "                                               Conditions  \\\n",
       "129846                                            Covid19   \n",
       "75546                                    Multiple Myeloma   \n",
       "461013  Dravet Syndrome|Epileptic Encephalopathies Ass...   \n",
       "260134                                      HIV Infection   \n",
       "4585           Critical COVID-19 With Respiratory Failure   \n",
       "\n",
       "                            Interventions Primary Outcome Measures  \\\n",
       "129846                  drug: t89 capsule                  unknown   \n",
       "75546                    drug: elotuzumab                  unknown   \n",
       "461013                  drug: stiripentol                  unknown   \n",
       "260134                    drug: efavirenz                  unknown   \n",
       "4585    drug: zyesami (aviptadil acetate)                  unknown   \n",
       "\n",
       "       Secondary Outcome Measures                             Sponsor  \\\n",
       "129846                       none         Tasly Pharmaceuticals, Inc.   \n",
       "75546                        none                    Sundar Jagannath   \n",
       "461013                       none  Cook Children's Health Care System   \n",
       "260134                       none                Bristol-Myers Squibb   \n",
       "4585                         none    APR Applied Pharma Research s.a.   \n",
       "\n",
       "                              Collaborators  Sex                        Age  \\\n",
       "129846  Tasly Pharmaceutical Group Co., Ltd  ALL  CHILD, ADULT, OLDER_ADULT   \n",
       "75546                  Bristol-Myers Squibb  ALL         ADULT, OLDER_ADULT   \n",
       "461013                                 none  ALL               CHILD, ADULT   \n",
       "260134                                 none  ALL                      CHILD   \n",
       "4585                                   none  ALL  CHILD, ADULT, OLDER_ADULT   \n",
       "\n",
       "          Phases  Enrollment Funder Type       Study Type Study Design  \\\n",
       "129846  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS      unknown   \n",
       "75546   NO PHASE          69       OTHER  EXPANDED_ACCESS      unknown   \n",
       "461013  NO PHASE          69       OTHER  EXPANDED_ACCESS      unknown   \n",
       "260134  NO PHASE          69    INDUSTRY  EXPANDED_ACCESS      unknown   \n",
       "4585    NO PHASE          69       OTHER  EXPANDED_ACCESS      unknown   \n",
       "\n",
       "       Start Date Primary Completion Date Completion Date First Posted  \\\n",
       "129846    unknown                 unknown         unknown   2020-11-27   \n",
       "75546     unknown                 unknown         unknown   2015-09-04   \n",
       "461013    unknown                 unknown         unknown   2014-09-12   \n",
       "260134    2000-09                 2010-12         2010-12   2005-09-13   \n",
       "4585      unknown                 unknown         unknown   2020-07-01   \n",
       "\n",
       "       Last Update Posted                                          Locations  \n",
       "129846         2023-08-08  MultiCare Health System, Tacoma, Washington, 9...  \n",
       "75546          2015-09-04  Icahn School.of Medicine at Mount Sinai, New Y...  \n",
       "461013         2020-02-05  Cook Children's Medical Center, Fort Worth, Te...  \n",
       "260134         2014-01-09  Local Institution, Phoenix, Arizona, 85016, Un...  \n",
       "4585           2023-02-03  Dignity Health-Mercy Gilbert Medical Center, G...  "
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['Study Status'] == 'NO_LONGER_AVAILABLE'].sample(5)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7326a1af-b3c9-47cd-bf40-1fbe0af1956d",
   "metadata": {},
   "source": [
    "Similarly with the AVAILABLE status, this category is missing information from `outcome_measures`, some `collaborators`, `Phases`, and `Study design`. We can remove these rows as well."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "f948d9fd-d14f-4340-8f83-afcbf9fb408c",
   "metadata": {},
   "outputs": [],
   "source": [
    "# drop rows where study status = NO_LONGER_AVAILABLE\n",
    "df.drop(index = df[df['Study Status'] == 'NO_LONGER_AVAILABLE'].index, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "6fc7229b-413c-4421-8989-a3cec6d48477",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                  263380\n",
       "RECRUITING                  66150\n",
       "UNKNOWN                     64828\n",
       "TERMINATED                  28014\n",
       "NOT_YET_RECRUITING          20055\n",
       "ACTIVE_NOT_RECRUITING       19702\n",
       "WITHDRAWN                   13716\n",
       "ENROLLING_BY_INVITATION      3931\n",
       "SUSPENDED                    1646\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ad5142b1-9f0f-44c2-b18b-62c7eede0585",
   "metadata": {},
   "source": [
    "The suspended status is when studies are halted for an indefinite amount of time, but can resume when proper conditions are met. Let's see where we can group these statuses."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "4efa25e1-6ad2-4811-b487-3c9aaeb097a3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>376035</th>\n",
       "      <td>Rare CNS Tumors Outcomes &amp;Risk</td>\n",
       "      <td>SUSPENDED</td>\n",
       "      <td>Background:\\n\\nPrimary tumors of the brain and...</td>\n",
       "      <td>NO</td>\n",
       "      <td>High Grade Meningioma|Ependymoma|Medulloblasto...</td>\n",
       "      <td>unknown</td>\n",
       "      <td>Relationship between health status and disease...</td>\n",
       "      <td>none</td>\n",
       "      <td>National Cancer Institute (NCI)</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>326</td>\n",
       "      <td>NIH</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2017-08-21</td>\n",
       "      <td>2025-02-01</td>\n",
       "      <td>2025-02-26</td>\n",
       "      <td>2017-08-16</td>\n",
       "      <td>2023-11-07</td>\n",
       "      <td>National Cancer Institute (NCI)/ Neuro-Oncolog...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>369308</th>\n",
       "      <td>Efficacy of Two Local Anesthetics on Quality o...</td>\n",
       "      <td>SUSPENDED</td>\n",
       "      <td>In this randomized controlled double-blinded s...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Pain, Postoperative|Quality of Life</td>\n",
       "      <td>drug: bupivacaine local anesthetic</td>\n",
       "      <td>Effects of Bupivacaine/Lidocaine will be asses...</td>\n",
       "      <td>none</td>\n",
       "      <td>NYU College of Dentistry</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>100</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2019-07-29</td>\n",
       "      <td>2024-10-01</td>\n",
       "      <td>2024-10-01</td>\n",
       "      <td>2021-03-09</td>\n",
       "      <td>2023-11-08</td>\n",
       "      <td>NYU College of Dentistry, New York, New York, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>191207</th>\n",
       "      <td>Effect of Internet Therapeutic Intervention on...</td>\n",
       "      <td>SUSPENDED</td>\n",
       "      <td>This project will test the effectiveness of an...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Type 2 Diabetes Mellitus</td>\n",
       "      <td>other: internet intervention</td>\n",
       "      <td>The primary endpoint is the A1c level or the c...</td>\n",
       "      <td>The secondary endpoints include severe hypogly...</td>\n",
       "      <td>Endocrine Research Society</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>50</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2010-02</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2010-02-02</td>\n",
       "      <td>2011-06-29</td>\n",
       "      <td>St. Paul's Hospital, Vancouver, British Columb...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>341760</th>\n",
       "      <td>The Leukemia and Lymphoma Society (LLS) T-cell...</td>\n",
       "      <td>SUSPENDED</td>\n",
       "      <td>Five hundred (500) patients participating in t...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Covid-19</td>\n",
       "      <td>diagnostic_test: immunoseq</td>\n",
       "      <td>Number of people who have developed T cells fr...</td>\n",
       "      <td>none</td>\n",
       "      <td>Larry Saltzman, MD</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>1000</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2021-05-20</td>\n",
       "      <td>2031-05-20</td>\n",
       "      <td>2031-05-20</td>\n",
       "      <td>2021-05-24</td>\n",
       "      <td>2022-08-17</td>\n",
       "      <td>Lymphoma and Leukemia Society, Rye Brook, New ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>135699</th>\n",
       "      <td>Pleural Suction Additional to Thoracostomy Tub...</td>\n",
       "      <td>SUSPENDED</td>\n",
       "      <td>The primary treatment for traumatic hemothorax...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Traumatic Hemothorax</td>\n",
       "      <td>procedure: pleural aspiration</td>\n",
       "      <td>Clotted hemothorax, Rate of clotted hemothorax...</td>\n",
       "      <td>Pleural aspiration procedure complications, De...</td>\n",
       "      <td>Hospital Pablo TobÃ³n Uribe</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>250</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2020-03-17</td>\n",
       "      <td>2024-03-05</td>\n",
       "      <td>2024-07-31</td>\n",
       "      <td>2020-08-25</td>\n",
       "      <td>2023-09-22</td>\n",
       "      <td>Pablo Tobon Uribe Hospital, Medellin, Antioqui...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              Study Title Study Status  \\\n",
       "376035                     Rare CNS Tumors Outcomes &Risk    SUSPENDED   \n",
       "369308  Efficacy of Two Local Anesthetics on Quality o...    SUSPENDED   \n",
       "191207  Effect of Internet Therapeutic Intervention on...    SUSPENDED   \n",
       "341760  The Leukemia and Lymphoma Society (LLS) T-cell...    SUSPENDED   \n",
       "135699  Pleural Suction Additional to Thoracostomy Tub...    SUSPENDED   \n",
       "\n",
       "                                            Brief Summary Study Results  \\\n",
       "376035  Background:\\n\\nPrimary tumors of the brain and...            NO   \n",
       "369308  In this randomized controlled double-blinded s...            NO   \n",
       "191207  This project will test the effectiveness of an...            NO   \n",
       "341760  Five hundred (500) patients participating in t...            NO   \n",
       "135699  The primary treatment for traumatic hemothorax...            NO   \n",
       "\n",
       "                                               Conditions  \\\n",
       "376035  High Grade Meningioma|Ependymoma|Medulloblasto...   \n",
       "369308                Pain, Postoperative|Quality of Life   \n",
       "191207                           Type 2 Diabetes Mellitus   \n",
       "341760                                           Covid-19   \n",
       "135699                               Traumatic Hemothorax   \n",
       "\n",
       "                             Interventions  \\\n",
       "376035                             unknown   \n",
       "369308  drug: bupivacaine local anesthetic   \n",
       "191207        other: internet intervention   \n",
       "341760          diagnostic_test: immunoseq   \n",
       "135699       procedure: pleural aspiration   \n",
       "\n",
       "                                 Primary Outcome Measures  \\\n",
       "376035  Relationship between health status and disease...   \n",
       "369308  Effects of Bupivacaine/Lidocaine will be asses...   \n",
       "191207  The primary endpoint is the A1c level or the c...   \n",
       "341760  Number of people who have developed T cells fr...   \n",
       "135699  Clotted hemothorax, Rate of clotted hemothorax...   \n",
       "\n",
       "                               Secondary Outcome Measures  \\\n",
       "376035                                               none   \n",
       "369308                                               none   \n",
       "191207  The secondary endpoints include severe hypogly...   \n",
       "341760                                               none   \n",
       "135699  Pleural aspiration procedure complications, De...   \n",
       "\n",
       "                                Sponsor Collaborators  Sex  \\\n",
       "376035  National Cancer Institute (NCI)          none  ALL   \n",
       "369308         NYU College of Dentistry          none  ALL   \n",
       "191207       Endocrine Research Society          none  ALL   \n",
       "341760               Larry Saltzman, MD          none  ALL   \n",
       "135699       Hospital Pablo TobÃ³n Uribe          none  ALL   \n",
       "\n",
       "                              Age    Phases  Enrollment Funder Type  \\\n",
       "376035         ADULT, OLDER_ADULT  NO PHASE         326         NIH   \n",
       "369308         ADULT, OLDER_ADULT    PHASE4         100       OTHER   \n",
       "191207         ADULT, OLDER_ADULT  NO PHASE          50       OTHER   \n",
       "341760  CHILD, ADULT, OLDER_ADULT  NO PHASE        1000       OTHER   \n",
       "135699         ADULT, OLDER_ADULT  NO PHASE         250       OTHER   \n",
       "\n",
       "            Study Type                                       Study Design  \\\n",
       "376035   OBSERVATIONAL          Observational Model: |Time Perspective: p   \n",
       "369308  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "191207  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "341760   OBSERVATIONAL          Observational Model: |Time Perspective: p   \n",
       "135699  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "\n",
       "        Start Date Primary Completion Date Completion Date First Posted  \\\n",
       "376035  2017-08-21              2025-02-01      2025-02-26   2017-08-16   \n",
       "369308  2019-07-29              2024-10-01      2024-10-01   2021-03-09   \n",
       "191207     2010-02                 unknown         unknown   2010-02-02   \n",
       "341760  2021-05-20              2031-05-20      2031-05-20   2021-05-24   \n",
       "135699  2020-03-17              2024-03-05      2024-07-31   2020-08-25   \n",
       "\n",
       "       Last Update Posted                                          Locations  \n",
       "376035         2023-11-07  National Cancer Institute (NCI)/ Neuro-Oncolog...  \n",
       "369308         2023-11-08  NYU College of Dentistry, New York, New York, ...  \n",
       "191207         2011-06-29  St. Paul's Hospital, Vancouver, British Columb...  \n",
       "341760         2022-08-17  Lymphoma and Leukemia Society, Rye Brook, New ...  \n",
       "135699         2023-09-22  Pablo Tobon Uribe Hospital, Medellin, Antioqui...  "
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['Study Status'] == 'SUSPENDED'].sample(5)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "72c09a70-e690-42b3-a14a-1f792e418264",
   "metadata": {},
   "source": [
    "If we look at the `Completion Date` column, we can see that some dates are set in the future (2025, 2028, etc). This means that these studies could potentially startup again when conditions are met. Therefore, we should remove these rows since they are neither completed or terminated."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "0733e46b-0fa8-4a4b-be37-bf83e09c2cb3",
   "metadata": {},
   "outputs": [],
   "source": [
    "# drop rows where study status = SUSPENDED\n",
    "df.drop(index = df[df['Study Status'] == 'SUSPENDED'].index, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "eece0f00-039e-4fb0-a807-049ddf776203",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                  263380\n",
       "RECRUITING                  66150\n",
       "UNKNOWN                     64828\n",
       "TERMINATED                  28014\n",
       "NOT_YET_RECRUITING          20055\n",
       "ACTIVE_NOT_RECRUITING       19702\n",
       "WITHDRAWN                   13716\n",
       "ENROLLING_BY_INVITATION      3931\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b156f067-1e0c-40e3-af86-1f7087a42bb8",
   "metadata": {},
   "source": [
    "Now let's look at `ENROLLING_BY_INVITATION` to see where we can group these statuses with."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "d851e8aa-25c0-4f82-884c-48c72bf223ab",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>284417</th>\n",
       "      <td>A Phase I Clinical Trial to Evaluate LIT-00814...</td>\n",
       "      <td>ENROLLING_BY_INVITATION</td>\n",
       "      <td>This study is a multi-center, open, dose-incre...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Advanced Solid Tumor</td>\n",
       "      <td>drug: lit-00814</td>\n",
       "      <td>Incidence of adverse events, Up to 28 days pos...</td>\n",
       "      <td>Objective remission rate (ORR), according to t...</td>\n",
       "      <td>LittDD Medicines Ltd</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>81</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2023-10-14</td>\n",
       "      <td>2025-10-30</td>\n",
       "      <td>2026-06-30</td>\n",
       "      <td>2024-01-12</td>\n",
       "      <td>2024-01-12</td>\n",
       "      <td>Cancer Hospital, Chinese Academy of Medical Sc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47610</th>\n",
       "      <td>Patient Reported Outcomes Study Using Electron...</td>\n",
       "      <td>ENROLLING_BY_INVITATION</td>\n",
       "      <td>This is a multicenter, open-label, randomized,...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Breast Cancer|Lung Cancer|Colorectal Cancer|Li...</td>\n",
       "      <td>other: e-pro monitoring</td>\n",
       "      <td>Overall Survival (OS), After enrollment to dea...</td>\n",
       "      <td>HRQoL EORTC Quality of Life of Cancer Patients...</td>\n",
       "      <td>Comprehensive Support Project for Oncology Res...</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>500</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2021-01-26</td>\n",
       "      <td>2026-03-31</td>\n",
       "      <td>2027-03-31</td>\n",
       "      <td>2023-07-05</td>\n",
       "      <td>2023-07-05</td>\n",
       "      <td>Kobe University Graduate School, Kobe, Hyogo, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>246177</th>\n",
       "      <td>Cohort/Ethics Study of Patients With Severe Al...</td>\n",
       "      <td>ENROLLING_BY_INVITATION</td>\n",
       "      <td>The purpose of this study is to develop a clin...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Liver Diseases, Alcoholic|Alcohol-Related Diso...</td>\n",
       "      <td>procedure: liver transplant</td>\n",
       "      <td>Number of participants who survived within 1 y...</td>\n",
       "      <td>Number of participants who self-report or have...</td>\n",
       "      <td>Johns Hopkins University</td>\n",
       "      <td>National Institute on Alcohol Abuse and Alcoho...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>300</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2020-04-01</td>\n",
       "      <td>2025-12-31</td>\n",
       "      <td>2025-12-31</td>\n",
       "      <td>2020-01-21</td>\n",
       "      <td>2023-04-11</td>\n",
       "      <td>Johns Hopkins University, Baltimore, Maryland,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28859</th>\n",
       "      <td>Basic Yoga and Meditation Techniques</td>\n",
       "      <td>ENROLLING_BY_INVITATION</td>\n",
       "      <td>Purpose of the research; To determine the effe...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Mediation</td>\n",
       "      <td>behavioral: meditation and yoga</td>\n",
       "      <td>Anxiety, The effect of yoga and meditation on ...</td>\n",
       "      <td>none</td>\n",
       "      <td>Ataturk University</td>\n",
       "      <td>none</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>66</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2024-02-15</td>\n",
       "      <td>2024-04-15</td>\n",
       "      <td>2024-09-15</td>\n",
       "      <td>2024-01-11</td>\n",
       "      <td>2024-01-11</td>\n",
       "      <td>Funda Ãitil Canbay, Erzurum, 25000, Turkey</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>407176</th>\n",
       "      <td>Experimental and Clinical Investigation of the...</td>\n",
       "      <td>ENROLLING_BY_INVITATION</td>\n",
       "      <td>The goal of this single-center, randomised dou...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Capsular Contracture Associated With Implant|F...</td>\n",
       "      <td>other: patient satisfaction questionnaire|diag...</td>\n",
       "      <td>wound bed fluid Immune cell profile (compositi...</td>\n",
       "      <td>Intracapsular immune cell composition, After 6...</td>\n",
       "      <td>Medical University Innsbruck</td>\n",
       "      <td>none</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>14</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2021-01-20</td>\n",
       "      <td>2024-01-20</td>\n",
       "      <td>2025-01-20</td>\n",
       "      <td>2022-12-13</td>\n",
       "      <td>2022-12-13</td>\n",
       "      <td>Medical University of Innsbruck, Department fo...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              Study Title  \\\n",
       "284417  A Phase I Clinical Trial to Evaluate LIT-00814...   \n",
       "47610   Patient Reported Outcomes Study Using Electron...   \n",
       "246177  Cohort/Ethics Study of Patients With Severe Al...   \n",
       "28859                Basic Yoga and Meditation Techniques   \n",
       "407176  Experimental and Clinical Investigation of the...   \n",
       "\n",
       "                   Study Status  \\\n",
       "284417  ENROLLING_BY_INVITATION   \n",
       "47610   ENROLLING_BY_INVITATION   \n",
       "246177  ENROLLING_BY_INVITATION   \n",
       "28859   ENROLLING_BY_INVITATION   \n",
       "407176  ENROLLING_BY_INVITATION   \n",
       "\n",
       "                                            Brief Summary Study Results  \\\n",
       "284417  This study is a multi-center, open, dose-incre...            NO   \n",
       "47610   This is a multicenter, open-label, randomized,...            NO   \n",
       "246177  The purpose of this study is to develop a clin...            NO   \n",
       "28859   Purpose of the research; To determine the effe...            NO   \n",
       "407176  The goal of this single-center, randomised dou...            NO   \n",
       "\n",
       "                                               Conditions  \\\n",
       "284417                               Advanced Solid Tumor   \n",
       "47610   Breast Cancer|Lung Cancer|Colorectal Cancer|Li...   \n",
       "246177  Liver Diseases, Alcoholic|Alcohol-Related Diso...   \n",
       "28859                                           Mediation   \n",
       "407176  Capsular Contracture Associated With Implant|F...   \n",
       "\n",
       "                                            Interventions  \\\n",
       "284417                                    drug: lit-00814   \n",
       "47610                             other: e-pro monitoring   \n",
       "246177                        procedure: liver transplant   \n",
       "28859                     behavioral: meditation and yoga   \n",
       "407176  other: patient satisfaction questionnaire|diag...   \n",
       "\n",
       "                                 Primary Outcome Measures  \\\n",
       "284417  Incidence of adverse events, Up to 28 days pos...   \n",
       "47610   Overall Survival (OS), After enrollment to dea...   \n",
       "246177  Number of participants who survived within 1 y...   \n",
       "28859   Anxiety, The effect of yoga and meditation on ...   \n",
       "407176  wound bed fluid Immune cell profile (compositi...   \n",
       "\n",
       "                               Secondary Outcome Measures  \\\n",
       "284417  Objective remission rate (ORR), according to t...   \n",
       "47610   HRQoL EORTC Quality of Life of Cancer Patients...   \n",
       "246177  Number of participants who self-report or have...   \n",
       "28859                                                none   \n",
       "407176  Intracapsular immune cell composition, After 6...   \n",
       "\n",
       "                                                  Sponsor  \\\n",
       "284417                               LittDD Medicines Ltd   \n",
       "47610   Comprehensive Support Project for Oncology Res...   \n",
       "246177                           Johns Hopkins University   \n",
       "28859                                  Ataturk University   \n",
       "407176                       Medical University Innsbruck   \n",
       "\n",
       "                                            Collaborators     Sex  \\\n",
       "284417                                               none     ALL   \n",
       "47610                                                none     ALL   \n",
       "246177  National Institute on Alcohol Abuse and Alcoho...     ALL   \n",
       "28859                                                none  FEMALE   \n",
       "407176                                               none  FEMALE   \n",
       "\n",
       "                       Age    Phases  Enrollment Funder Type      Study Type  \\\n",
       "284417  ADULT, OLDER_ADULT    PHASE1          81    INDUSTRY  INTERVENTIONAL   \n",
       "47610   ADULT, OLDER_ADULT  NO PHASE         500       OTHER  INTERVENTIONAL   \n",
       "246177  ADULT, OLDER_ADULT  NO PHASE         300       OTHER   OBSERVATIONAL   \n",
       "28859                ADULT  NO PHASE          66       OTHER  INTERVENTIONAL   \n",
       "407176  ADULT, OLDER_ADULT  NO PHASE          14       OTHER  INTERVENTIONAL   \n",
       "\n",
       "                                             Study Design  Start Date  \\\n",
       "284417  Allocation: NON_RANDOMIZED|Intervention Model:...  2023-10-14   \n",
       "47610   Allocation: RANDOMIZED|Intervention Model: PAR...  2021-01-26   \n",
       "246177          Observational Model: |Time Perspective: p  2020-04-01   \n",
       "28859   Allocation: RANDOMIZED|Intervention Model: PAR...  2024-02-15   \n",
       "407176  Allocation: RANDOMIZED|Intervention Model: PAR...  2021-01-20   \n",
       "\n",
       "       Primary Completion Date Completion Date First Posted  \\\n",
       "284417              2025-10-30      2026-06-30   2024-01-12   \n",
       "47610               2026-03-31      2027-03-31   2023-07-05   \n",
       "246177              2025-12-31      2025-12-31   2020-01-21   \n",
       "28859               2024-04-15      2024-09-15   2024-01-11   \n",
       "407176              2024-01-20      2025-01-20   2022-12-13   \n",
       "\n",
       "       Last Update Posted                                          Locations  \n",
       "284417         2024-01-12  Cancer Hospital, Chinese Academy of Medical Sc...  \n",
       "47610          2023-07-05  Kobe University Graduate School, Kobe, Hyogo, ...  \n",
       "246177         2023-04-11  Johns Hopkins University, Baltimore, Maryland,...  \n",
       "28859          2024-01-11         Funda Ãitil Canbay, Erzurum, 25000, Turkey  \n",
       "407176         2022-12-13  Medical University of Innsbruck, Department fo...  "
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['Study Status'] == 'ENROLLING_BY_INVITATION'].sample(5)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3471d96f-2966-4605-926f-950cbe87c777",
   "metadata": {},
   "source": [
    "The `ENROLLING_BY_INVITATION` status consists of studies that are currently selecting participants from a predetermine population for the research. Since this status is not within our scope of the problem, we can also remove these rows."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "526897d0-3768-4b13-8720-cb43cb9d8e11",
   "metadata": {},
   "outputs": [],
   "source": [
    "# drop rows where study status = `ENROLLING_BY_INVITATION`\n",
    "df.drop(index = df[df['Study Status'] == 'ENROLLING_BY_INVITATION'].index, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "61bebed5-9fc8-46aa-be62-001594d5edb6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                263380\n",
       "RECRUITING                66150\n",
       "UNKNOWN                   64828\n",
       "TERMINATED                28014\n",
       "NOT_YET_RECRUITING        20055\n",
       "ACTIVE_NOT_RECRUITING     19702\n",
       "WITHDRAWN                 13716\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cdd79bd2-bb74-440d-b94b-4049975af40f",
   "metadata": {},
   "source": [
    "Next we will look at the `WITHDRAWN` status which has 13,716 studies."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "5447b29a-438c-436b-81e5-83fcb2b27ef1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>479328</th>\n",
       "      <td>The Effect of Metoprolol on Anaesthesia, the N...</td>\n",
       "      <td>WITHDRAWN</td>\n",
       "      <td>The purpose of the study is to test the effect...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>drug: metoprolol|drug: normal saline</td>\n",
       "      <td>Anaesthesia, Total consumption of desflurane, ...</td>\n",
       "      <td>Safety and tolerability, Number of patients wi...</td>\n",
       "      <td>Kuopio University Hospital</td>\n",
       "      <td>none</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2018-03-21</td>\n",
       "      <td>2018-03-21</td>\n",
       "      <td>2018-03-21</td>\n",
       "      <td>2014-10-21</td>\n",
       "      <td>2018-03-22</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>251376</th>\n",
       "      <td>Fractional CO2 Laser for the Treatment of Lich...</td>\n",
       "      <td>WITHDRAWN</td>\n",
       "      <td>This study will assess the safety and efficacy...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Lichen Planus Pigmentosus</td>\n",
       "      <td>device: co2 fractional laser</td>\n",
       "      <td>Improvement in dyspigmentation at 12 weeks pos...</td>\n",
       "      <td>Overall Subject Satisfaction assessed at 12 we...</td>\n",
       "      <td>University of Texas Southwestern Medical Center</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2022-08-01</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2021-12-27</td>\n",
       "      <td>2022-08-02</td>\n",
       "      <td>UT Southwestern Medical Center, Dallas, Texas,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>274089</th>\n",
       "      <td>Natural History of Granulomatosis With Polyang...</td>\n",
       "      <td>WITHDRAWN</td>\n",
       "      <td>The ultimate goal of this prospective natural ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Granulomatosis With Polyangiitis</td>\n",
       "      <td>procedure: airway assessment|procedure: rheuma...</td>\n",
       "      <td>Time to recurrent intervention (TTR), The time...</td>\n",
       "      <td>Patient Reported Outcome Measures, Patient Qua...</td>\n",
       "      <td>Vanderbilt University Medical Center</td>\n",
       "      <td>North American Airway Collaborative (NoAAC)|Va...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2020-12</td>\n",
       "      <td>2022-05</td>\n",
       "      <td>2023-05</td>\n",
       "      <td>2017-06-09</td>\n",
       "      <td>2020-08-25</td>\n",
       "      <td>Vanderbilt University Medical Center, Nashvill...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>300069</th>\n",
       "      <td>Effects of Antimuscarinic Drugs on Overactive ...</td>\n",
       "      <td>WITHDRAWN</td>\n",
       "      <td>The purpose of this study is to check whether ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Overactive Bladder</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>Meir Medical Center</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2010-09</td>\n",
       "      <td>2011-12</td>\n",
       "      <td>2012-12</td>\n",
       "      <td>2010-09-29</td>\n",
       "      <td>2013-09-26</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>418966</th>\n",
       "      <td>Safety and Efficacy Study of TLL018 in the Tre...</td>\n",
       "      <td>WITHDRAWN</td>\n",
       "      <td>A study to investigate the safety and efficacy...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Ulcerative Colitis</td>\n",
       "      <td>drug: tll018|other: placebo</td>\n",
       "      <td>Percentage of subjects who achieved clinical r...</td>\n",
       "      <td>Percentage of subjects with endoscopic improve...</td>\n",
       "      <td>TLL Pharmaceutical, LLC</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>0</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2022-12-30</td>\n",
       "      <td>2023-07-01</td>\n",
       "      <td>2023-12-30</td>\n",
       "      <td>2021-11-16</td>\n",
       "      <td>2022-05-13</td>\n",
       "      <td>Gastroenterology Research of San Antonio (GERS...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              Study Title Study Status  \\\n",
       "479328  The Effect of Metoprolol on Anaesthesia, the N...    WITHDRAWN   \n",
       "251376  Fractional CO2 Laser for the Treatment of Lich...    WITHDRAWN   \n",
       "274089  Natural History of Granulomatosis With Polyang...    WITHDRAWN   \n",
       "300069  Effects of Antimuscarinic Drugs on Overactive ...    WITHDRAWN   \n",
       "418966  Safety and Efficacy Study of TLL018 in the Tre...    WITHDRAWN   \n",
       "\n",
       "                                            Brief Summary Study Results  \\\n",
       "479328  The purpose of the study is to test the effect...            NO   \n",
       "251376  This study will assess the safety and efficacy...            NO   \n",
       "274089  The ultimate goal of this prospective natural ...            NO   \n",
       "300069  The purpose of this study is to check whether ...            NO   \n",
       "418966  A study to investigate the safety and efficacy...            NO   \n",
       "\n",
       "                              Conditions  \\\n",
       "479328                     Breast Cancer   \n",
       "251376         Lichen Planus Pigmentosus   \n",
       "274089  Granulomatosis With Polyangiitis   \n",
       "300069                Overactive Bladder   \n",
       "418966                Ulcerative Colitis   \n",
       "\n",
       "                                            Interventions  \\\n",
       "479328               drug: metoprolol|drug: normal saline   \n",
       "251376                       device: co2 fractional laser   \n",
       "274089  procedure: airway assessment|procedure: rheuma...   \n",
       "300069                                            unknown   \n",
       "418966                        drug: tll018|other: placebo   \n",
       "\n",
       "                                 Primary Outcome Measures  \\\n",
       "479328  Anaesthesia, Total consumption of desflurane, ...   \n",
       "251376  Improvement in dyspigmentation at 12 weeks pos...   \n",
       "274089  Time to recurrent intervention (TTR), The time...   \n",
       "300069                                            unknown   \n",
       "418966  Percentage of subjects who achieved clinical r...   \n",
       "\n",
       "                               Secondary Outcome Measures  \\\n",
       "479328  Safety and tolerability, Number of patients wi...   \n",
       "251376  Overall Subject Satisfaction assessed at 12 we...   \n",
       "274089  Patient Reported Outcome Measures, Patient Qua...   \n",
       "300069                                               none   \n",
       "418966  Percentage of subjects with endoscopic improve...   \n",
       "\n",
       "                                                Sponsor  \\\n",
       "479328                       Kuopio University Hospital   \n",
       "251376  University of Texas Southwestern Medical Center   \n",
       "274089             Vanderbilt University Medical Center   \n",
       "300069                              Meir Medical Center   \n",
       "418966                          TLL Pharmaceutical, LLC   \n",
       "\n",
       "                                            Collaborators     Sex  \\\n",
       "479328                                               none  FEMALE   \n",
       "251376                                               none     ALL   \n",
       "274089  North American Airway Collaborative (NoAAC)|Va...     ALL   \n",
       "300069                                               none     ALL   \n",
       "418966                                               none     ALL   \n",
       "\n",
       "                       Age    Phases  Enrollment Funder Type      Study Type  \\\n",
       "479328  ADULT, OLDER_ADULT    PHASE3           0       OTHER  INTERVENTIONAL   \n",
       "251376  ADULT, OLDER_ADULT  NO PHASE           0       OTHER  INTERVENTIONAL   \n",
       "274089  ADULT, OLDER_ADULT  NO PHASE           0       OTHER   OBSERVATIONAL   \n",
       "300069  ADULT, OLDER_ADULT  NO PHASE           0       OTHER   OBSERVATIONAL   \n",
       "418966  ADULT, OLDER_ADULT    PHASE2           0    INDUSTRY  INTERVENTIONAL   \n",
       "\n",
       "                                             Study Design  Start Date  \\\n",
       "479328  Allocation: RANDOMIZED|Intervention Model: PAR...  2018-03-21   \n",
       "251376  Allocation: NON_RANDOMIZED|Intervention Model:...  2022-08-01   \n",
       "274089          Observational Model: |Time Perspective: p     2020-12   \n",
       "300069          Observational Model: |Time Perspective: p     2010-09   \n",
       "418966  Allocation: RANDOMIZED|Intervention Model: PAR...  2022-12-30   \n",
       "\n",
       "       Primary Completion Date Completion Date First Posted  \\\n",
       "479328              2018-03-21      2018-03-21   2014-10-21   \n",
       "251376              2022-12-31      2022-12-31   2021-12-27   \n",
       "274089                 2022-05         2023-05   2017-06-09   \n",
       "300069                 2011-12         2012-12   2010-09-29   \n",
       "418966              2023-07-01      2023-12-30   2021-11-16   \n",
       "\n",
       "       Last Update Posted                                          Locations  \n",
       "479328         2018-03-22                                            unknown  \n",
       "251376         2022-08-02  UT Southwestern Medical Center, Dallas, Texas,...  \n",
       "274089         2020-08-25  Vanderbilt University Medical Center, Nashvill...  \n",
       "300069         2013-09-26                                            unknown  \n",
       "418966         2022-05-13  Gastroenterology Research of San Antonio (GERS...  "
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['Study Status'] == 'WITHDRAWN'].sample(5)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fb95a431-cfef-419c-a967-040c4b8064d1",
   "metadata": {},
   "source": [
    "Withdrawn are finished studies that have stopped prematurely before enrolling it's first participant. Since this status essentially has the same meaning as the terminated status, we will group this in the same category."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "8ae62cb7-15d6-477b-886d-bf7f86f3040d",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Use np.where() to replace 'WITHDRAWN' with 'TERMINATED'\n",
    "df['Study Status'] = np.where(df['Study Status'] == 'WITHDRAWN', 'TERMINATED', df['Study Status'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "75b2967a-c43a-4bf9-afb5-8bdb9e2a748f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED                263380\n",
       "RECRUITING                66150\n",
       "UNKNOWN                   64828\n",
       "TERMINATED                41730\n",
       "NOT_YET_RECRUITING        20055\n",
       "ACTIVE_NOT_RECRUITING     19702\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "14d17cfb-de89-4377-8a77-5aabe31ad216",
   "metadata": {},
   "source": [
    "`RECRUITING`, `NOT_YET_RECRUITING`, and `ACTIVE_NOT_RECRUITING` are all study statuses that are **on-going** and is not finished yet. So let's remove those rows as well since it's not within the scope of the problem."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "9b3a47a5-1754-4703-8ecc-eabfdede9a75",
   "metadata": {},
   "outputs": [],
   "source": [
    "# drop rows where study status = RECRUITING, NOT_YET_RECRUITING, and ACTIVE_NOT_RECRUITING\n",
    "df.drop(index=df[df['Study Status'].isin(['RECRUITING', 'NOT_YET_RECRUITING', 'ACTIVE_NOT_RECRUITING'])].index, inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "bb500bd2-a998-4873-add7-a5fabd948d81",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED     263380\n",
       "UNKNOWN        64828\n",
       "TERMINATED     41730\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7dc4f32b-2580-43e5-b521-1628e65c4085",
   "metadata": {},
   "source": [
    "Finally, we should check the `UNKNOWN` status to see if we can group or remove them."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "ac85ee3a-47c0-40fb-bb09-738373a2b05e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>104225</th>\n",
       "      <td>To Investigate the Influence of Ethnicity in M...</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>The overall objective of this study is to inve...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Healthy|Overweight|Obesity</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>none</td>\n",
       "      <td>National University Hospital, Singapore</td>\n",
       "      <td>National Medical Research Council (NMRC), Sing...</td>\n",
       "      <td>MALE</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>200</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2009-07</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2009-10-02</td>\n",
       "      <td>2010-03-02</td>\n",
       "      <td>National University Hospital, Singapore, Singa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>145951</th>\n",
       "      <td>Korea University Anam Hospital Optical Coheren...</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>All comer registry who had undergone intravasc...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Coronary Artery Disease|Optical Coherence Tomo...</td>\n",
       "      <td>device: optical coherence tomography</td>\n",
       "      <td>Incidence of participants with Major Adverse C...</td>\n",
       "      <td>none</td>\n",
       "      <td>Korea University Anam Hospital</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>2000</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2016-04</td>\n",
       "      <td>2019-12</td>\n",
       "      <td>2021-12</td>\n",
       "      <td>2016-11-17</td>\n",
       "      <td>2016-11-17</td>\n",
       "      <td>Korea University Anam Hospital, Seoul, 136-705...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>195299</th>\n",
       "      <td>Shift Work Health Effects</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>To identify the health effects of shift work o...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Shift-work Disorder</td>\n",
       "      <td>other: the standard shiftwork index questionna...</td>\n",
       "      <td>complete blood picture, total leucocytic count...</td>\n",
       "      <td>none</td>\n",
       "      <td>Assiut University</td>\n",
       "      <td>none</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>108</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2021-06</td>\n",
       "      <td>2022-06</td>\n",
       "      <td>2022-12</td>\n",
       "      <td>2021-03-24</td>\n",
       "      <td>2021-03-24</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91785</th>\n",
       "      <td>Eye Drops Study for Myopia Control in Schoolch...</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>The myopia prevalence in schoolchildren is hig...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Myopia, Progressive|Atropine Allergy</td>\n",
       "      <td>drug: eye drops</td>\n",
       "      <td>Cycloplegic spherical refraction change measur...</td>\n",
       "      <td>Intraocular pressure (mmHg) by non-contact ton...</td>\n",
       "      <td>Chang Gung Memorial Hospital</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>150</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2014-10-20</td>\n",
       "      <td>2019-12-31</td>\n",
       "      <td>2019-12-31</td>\n",
       "      <td>2018-01-18</td>\n",
       "      <td>2018-01-18</td>\n",
       "      <td>Kaohsiung Chang Gung Memorial Hospital, Kaohsi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>139236</th>\n",
       "      <td>A Prospective Trial to Explore the Efficacy of...</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>Fibromyalgia Syndrome (FMS) is a highly preval...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Fibromyalgia</td>\n",
       "      <td>device: dtms</td>\n",
       "      <td>pain intensity - past 24h, Change in self-repo...</td>\n",
       "      <td>pain dimensions, 1. Change of sensory and affe...</td>\n",
       "      <td>Shalvata Mental Health Center</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>30</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>2014-03</td>\n",
       "      <td>2015-03</td>\n",
       "      <td>2015-06</td>\n",
       "      <td>2014-03-11</td>\n",
       "      <td>2014-03-11</td>\n",
       "      <td>Shalvata MHC, Hod Ha-sharon, Israel</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102734</th>\n",
       "      <td>Effects of Compression Stockings in Asthma Sym...</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>Nocturnal worsening of asthma is common. It is...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Asthma</td>\n",
       "      <td>other: compression stockings|other: control</td>\n",
       "      <td>Effect of wearing compression stockings on red...</td>\n",
       "      <td>none</td>\n",
       "      <td>University Health Network, Toronto</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>40</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>2017-02-21</td>\n",
       "      <td>2017-11-01</td>\n",
       "      <td>2017-11-01</td>\n",
       "      <td>2017-10-06</td>\n",
       "      <td>2017-10-09</td>\n",
       "      <td>Toronto Rehabilitation Institute (TRI), Toront...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19900</th>\n",
       "      <td>Developing a Functional Cure for HIV Disease: ...</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>Clinical specimens are required from HIV posit...</td>\n",
       "      <td>NO</td>\n",
       "      <td>HIV Infections</td>\n",
       "      <td>unknown</td>\n",
       "      <td>Collection of clinical specimens, The blood sa...</td>\n",
       "      <td>none</td>\n",
       "      <td>American Gene Technologies International Inc.</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>24</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2017-07-25</td>\n",
       "      <td>2021-02-07</td>\n",
       "      <td>2021-02-07</td>\n",
       "      <td>2017-07-12</td>\n",
       "      <td>2020-09-16</td>\n",
       "      <td>Providence Hospital, Washington, District of C...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44296</th>\n",
       "      <td>Quality of Life in Asthmatic Children at Schoo...</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>Asthma is the most common chronic disease in c...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Asthma</td>\n",
       "      <td>behavioral: educational program: consultation ...</td>\n",
       "      <td>AUQUEI questionnaire (Asthma Caregiver's Quali...</td>\n",
       "      <td>Clinical control of asthma measured by the Ast...</td>\n",
       "      <td>University Hospital, Clermont-Ferrand</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>40</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2011-12</td>\n",
       "      <td>2012-04</td>\n",
       "      <td>2012-10</td>\n",
       "      <td>2011-11-22</td>\n",
       "      <td>2011-11-22</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>140983</th>\n",
       "      <td>Protein and Magnesium in Ulcerative Colitis</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>The aim of the study is to improve the quality...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Inflammatory Bowel Diseases|Colitis, Ulcerativ...</td>\n",
       "      <td>dietary_supplement: magnesium acetate mixture ...</td>\n",
       "      <td>24 hour urine carbamide (mmol/d), Change in 24...</td>\n",
       "      <td>24 hour urine carbamide (mmol/d), Change in 24...</td>\n",
       "      <td>University of Aarhus</td>\n",
       "      <td>University of Copenhagen</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>36</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2022-02-08</td>\n",
       "      <td>2022-06-01</td>\n",
       "      <td>2022-07-01</td>\n",
       "      <td>2022-03-09</td>\n",
       "      <td>2022-03-09</td>\n",
       "      <td>Aarhus University Hospital, Aarhus N, 8200, De...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>479654</th>\n",
       "      <td>Trial of Myocet in Metastatic Breast Cancer</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>The purpose of the study is to examine the saf...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>drug: myocet</td>\n",
       "      <td>Progression-Free Survival</td>\n",
       "      <td>Overall Survival|Safety</td>\n",
       "      <td>Sopherion Therapeutics</td>\n",
       "      <td>none</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>363</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2006-01</td>\n",
       "      <td>unknown</td>\n",
       "      <td>unknown</td>\n",
       "      <td>2006-02-22</td>\n",
       "      <td>2009-03-31</td>\n",
       "      <td>Scripps Cancer Center Clinical Research, San D...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              Study Title Study Status  \\\n",
       "104225  To Investigate the Influence of Ethnicity in M...      UNKNOWN   \n",
       "145951  Korea University Anam Hospital Optical Coheren...      UNKNOWN   \n",
       "195299                          Shift Work Health Effects      UNKNOWN   \n",
       "91785   Eye Drops Study for Myopia Control in Schoolch...      UNKNOWN   \n",
       "139236  A Prospective Trial to Explore the Efficacy of...      UNKNOWN   \n",
       "102734  Effects of Compression Stockings in Asthma Sym...      UNKNOWN   \n",
       "19900   Developing a Functional Cure for HIV Disease: ...      UNKNOWN   \n",
       "44296   Quality of Life in Asthmatic Children at Schoo...      UNKNOWN   \n",
       "140983        Protein and Magnesium in Ulcerative Colitis      UNKNOWN   \n",
       "479654        Trial of Myocet in Metastatic Breast Cancer      UNKNOWN   \n",
       "\n",
       "                                            Brief Summary Study Results  \\\n",
       "104225  The overall objective of this study is to inve...            NO   \n",
       "145951  All comer registry who had undergone intravasc...            NO   \n",
       "195299  To identify the health effects of shift work o...            NO   \n",
       "91785   The myopia prevalence in schoolchildren is hig...            NO   \n",
       "139236  Fibromyalgia Syndrome (FMS) is a highly preval...            NO   \n",
       "102734  Nocturnal worsening of asthma is common. It is...            NO   \n",
       "19900   Clinical specimens are required from HIV posit...            NO   \n",
       "44296   Asthma is the most common chronic disease in c...            NO   \n",
       "140983  The aim of the study is to improve the quality...            NO   \n",
       "479654  The purpose of the study is to examine the saf...            NO   \n",
       "\n",
       "                                               Conditions  \\\n",
       "104225                         Healthy|Overweight|Obesity   \n",
       "145951  Coronary Artery Disease|Optical Coherence Tomo...   \n",
       "195299                                Shift-work Disorder   \n",
       "91785                Myopia, Progressive|Atropine Allergy   \n",
       "139236                                       Fibromyalgia   \n",
       "102734                                             Asthma   \n",
       "19900                                      HIV Infections   \n",
       "44296                                              Asthma   \n",
       "140983  Inflammatory Bowel Diseases|Colitis, Ulcerativ...   \n",
       "479654                                      Breast Cancer   \n",
       "\n",
       "                                            Interventions  \\\n",
       "104225                                            unknown   \n",
       "145951               device: optical coherence tomography   \n",
       "195299  other: the standard shiftwork index questionna...   \n",
       "91785                                     drug: eye drops   \n",
       "139236                                       device: dtms   \n",
       "102734        other: compression stockings|other: control   \n",
       "19900                                             unknown   \n",
       "44296   behavioral: educational program: consultation ...   \n",
       "140983  dietary_supplement: magnesium acetate mixture ...   \n",
       "479654                                       drug: myocet   \n",
       "\n",
       "                                 Primary Outcome Measures  \\\n",
       "104225                                            unknown   \n",
       "145951  Incidence of participants with Major Adverse C...   \n",
       "195299  complete blood picture, total leucocytic count...   \n",
       "91785   Cycloplegic spherical refraction change measur...   \n",
       "139236  pain intensity - past 24h, Change in self-repo...   \n",
       "102734  Effect of wearing compression stockings on red...   \n",
       "19900   Collection of clinical specimens, The blood sa...   \n",
       "44296   AUQUEI questionnaire (Asthma Caregiver's Quali...   \n",
       "140983  24 hour urine carbamide (mmol/d), Change in 24...   \n",
       "479654                          Progression-Free Survival   \n",
       "\n",
       "                               Secondary Outcome Measures  \\\n",
       "104225                                               none   \n",
       "145951                                               none   \n",
       "195299                                               none   \n",
       "91785   Intraocular pressure (mmHg) by non-contact ton...   \n",
       "139236  pain dimensions, 1. Change of sensory and affe...   \n",
       "102734                                               none   \n",
       "19900                                                none   \n",
       "44296   Clinical control of asthma measured by the Ast...   \n",
       "140983  24 hour urine carbamide (mmol/d), Change in 24...   \n",
       "479654                            Overall Survival|Safety   \n",
       "\n",
       "                                              Sponsor  \\\n",
       "104225        National University Hospital, Singapore   \n",
       "145951                 Korea University Anam Hospital   \n",
       "195299                              Assiut University   \n",
       "91785                    Chang Gung Memorial Hospital   \n",
       "139236                  Shalvata Mental Health Center   \n",
       "102734             University Health Network, Toronto   \n",
       "19900   American Gene Technologies International Inc.   \n",
       "44296           University Hospital, Clermont-Ferrand   \n",
       "140983                           University of Aarhus   \n",
       "479654                         Sopherion Therapeutics   \n",
       "\n",
       "                                            Collaborators     Sex  \\\n",
       "104225  National Medical Research Council (NMRC), Sing...    MALE   \n",
       "145951                                               none     ALL   \n",
       "195299                                               none  FEMALE   \n",
       "91785                                                none     ALL   \n",
       "139236                                               none     ALL   \n",
       "102734                                               none     ALL   \n",
       "19900                                                none     ALL   \n",
       "44296                                                none     ALL   \n",
       "140983                           University of Copenhagen     ALL   \n",
       "479654                                               none  FEMALE   \n",
       "\n",
       "                              Age    Phases  Enrollment Funder Type  \\\n",
       "104225                      ADULT  NO PHASE         200       OTHER   \n",
       "145951  CHILD, ADULT, OLDER_ADULT  NO PHASE        2000       OTHER   \n",
       "195299                      ADULT  NO PHASE         108       OTHER   \n",
       "91785                       CHILD  NO PHASE         150       OTHER   \n",
       "139236         ADULT, OLDER_ADULT    PHASE2          30       OTHER   \n",
       "102734         ADULT, OLDER_ADULT  NO PHASE          40       OTHER   \n",
       "19900                       ADULT  NO PHASE          24    INDUSTRY   \n",
       "44296                       CHILD  NO PHASE          40       OTHER   \n",
       "140983         ADULT, OLDER_ADULT  NO PHASE          36       OTHER   \n",
       "479654         ADULT, OLDER_ADULT    PHASE3         363    INDUSTRY   \n",
       "\n",
       "            Study Type                                       Study Design  \\\n",
       "104225   OBSERVATIONAL          Observational Model: |Time Perspective: p   \n",
       "145951   OBSERVATIONAL          Observational Model: |Time Perspective: p   \n",
       "195299   OBSERVATIONAL          Observational Model: |Time Perspective: p   \n",
       "91785   INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "139236  INTERVENTIONAL  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
       "102734  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...   \n",
       "19900    OBSERVATIONAL          Observational Model: |Time Perspective: p   \n",
       "44296   INTERVENTIONAL  Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
       "140983  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "479654  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "\n",
       "        Start Date Primary Completion Date Completion Date First Posted  \\\n",
       "104225     2009-07                 unknown         unknown   2009-10-02   \n",
       "145951     2016-04                 2019-12         2021-12   2016-11-17   \n",
       "195299     2021-06                 2022-06         2022-12   2021-03-24   \n",
       "91785   2014-10-20              2019-12-31      2019-12-31   2018-01-18   \n",
       "139236     2014-03                 2015-03         2015-06   2014-03-11   \n",
       "102734  2017-02-21              2017-11-01      2017-11-01   2017-10-06   \n",
       "19900   2017-07-25              2021-02-07      2021-02-07   2017-07-12   \n",
       "44296      2011-12                 2012-04         2012-10   2011-11-22   \n",
       "140983  2022-02-08              2022-06-01      2022-07-01   2022-03-09   \n",
       "479654     2006-01                 unknown         unknown   2006-02-22   \n",
       "\n",
       "       Last Update Posted                                          Locations  \n",
       "104225         2010-03-02  National University Hospital, Singapore, Singa...  \n",
       "145951         2016-11-17  Korea University Anam Hospital, Seoul, 136-705...  \n",
       "195299         2021-03-24                                            unknown  \n",
       "91785          2018-01-18  Kaohsiung Chang Gung Memorial Hospital, Kaohsi...  \n",
       "139236         2014-03-11                Shalvata MHC, Hod Ha-sharon, Israel  \n",
       "102734         2017-10-09  Toronto Rehabilitation Institute (TRI), Toront...  \n",
       "19900          2020-09-16  Providence Hospital, Washington, District of C...  \n",
       "44296          2011-11-22                                            unknown  \n",
       "140983         2022-03-09  Aarhus University Hospital, Aarhus N, 8200, De...  \n",
       "479654         2009-03-31  Scripps Cancer Center Clinical Research, San D...  "
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['Study Status'] == 'UNKNOWN'].sample(10)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "28af6cde-eb56-4963-a9a4-191ffb51927b",
   "metadata": {},
   "source": [
    "Since we don't know the status of these studies and we cannot classify them based on other columns without a strong bias. We will just drop all the unknown study status for now."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "4514fb3e-5b31-4af8-8fa4-8ef7f123537f",
   "metadata": {},
   "outputs": [],
   "source": [
    "# drop rows where study status = `UNKNOWN`\n",
    "df.drop(index = df[df['Study Status'] == 'UNKNOWN'].index, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "5af965e9-cae0-41da-818c-f8729bc75e4b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "COMPLETED     263380\n",
       "TERMINATED     41730\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df['Study Status'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4702f060-2b7a-4063-9836-a116fda0f28b",
   "metadata": {},
   "source": [
    "Great! Now that we have removed all the statuses that aren't related to predicting clinical trial terminations, we can convert the study status into binary values.\n",
    "\n",
    "Next, we need to reset the index for our dataframe and convert the terminated status into 1 and the completed status into 0."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "8e30e658-b219-46b6-9d11-464f9ff8553f",
   "metadata": {},
   "outputs": [],
   "source": [
    "# reset dataframe index\n",
    "df.reset_index(drop = True, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "23ad8998-b014-42c7-9c8e-24f399cb5a08",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Convert Study Status values into binary\n",
    "df['Study Status'] = np.where(df['Study Status'] == 'TERMINATED', 1, 0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "cafb437d-d981-4ae9-bcae-4fa1688739ad",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Status\n",
       "0    0.86323\n",
       "1    0.13677\n",
       "Name: proportion, dtype: float64"
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity + distribution of data check\n",
    "df['Study Status'].value_counts(normalize=True)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f09ec54a-0078-467a-b390-4abd20bd1947",
   "metadata": {},
   "source": [
    "**Important Notes:**\n",
    "Wow there is a massive data imbalance in our dataset where 86.3% are completed and 13.7% are terminated trials. If we did not have a predictive model and guessed whether trials are completed or terminated, 86.3% of the time you would get a completed result. Therefore to analyze our models, we definitely need to look at precision and recall metrics to find out how good the model really is.\n",
    "\n",
    "To improve our data imbalance, we could perform some upsampling/desampling of the data during modelling to see how that will affect our results."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "13177f4c-2e6e-4566-b79c-ebeba5c61e91",
   "metadata": {},
   "source": [
    "Next, let's look into the `Study Results` which can be turned into a binary column as well."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "29654ac0-bfa6-4456-92e9-620980517fff",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Study Results\n",
       "NO     0.799413\n",
       "YES    0.200587\n",
       "Name: proportion, dtype: float64"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['Study Results'].value_counts(normalize = True)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6087556c-1c16-439f-b6e7-d285e9fe62e1",
   "metadata": {},
   "source": [
    "Around 80% of the studies did not post results. I wonder if this would have any affect on clinical trial terminations..."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "e1a51e1d-3dcd-48e3-aa68-f232d1617bad",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Convert Study Results into binary\n",
    "df['Study Results'] = np.where(df['Study Results'] == 'YES', 1, 0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "f5eb26b5-8676-4df3-abfe-6feae362fbf3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Effectiveness of a Problem-solving Interventio...</td>\n",
       "      <td>0</td>\n",
       "      <td>We will conduct a two-arm individually randomi...</td>\n",
       "      <td>0</td>\n",
       "      <td>Mental Health Issue (E.G., Depression, Psychos...</td>\n",
       "      <td>behavioral: pride 'step 1' problem-solving int...</td>\n",
       "      <td>Mental health symptoms, The Strengths and Diff...</td>\n",
       "      <td>Mental health symptoms, The adolescent-reporte...</td>\n",
       "      <td>Sangath</td>\n",
       "      <td>Harvard Medical School (HMS and HSDM)|London S...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>CHILD, ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>250</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2018-08-20</td>\n",
       "      <td>2019-01-20</td>\n",
       "      <td>2019-02-28</td>\n",
       "      <td>2018-08-14</td>\n",
       "      <td>2019-05-21</td>\n",
       "      <td>Sangath, New Delhi, Delhi, 110016, India</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Investigating the Effect of a Prenatal Family ...</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to measure the di...</td>\n",
       "      <td>0</td>\n",
       "      <td>Focus: Contraceptive Counseling|Focus: Postpar...</td>\n",
       "      <td>other: family planning counseling let by commu...</td>\n",
       "      <td>Self-reported contraceptive use, 6 months post...</td>\n",
       "      <td>Intent to use contraception in the future, 6 m...</td>\n",
       "      <td>Planned Parenthood League of Massachusetts</td>\n",
       "      <td>Society for Family Planning Research Fund</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>176</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2013-08</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2013-05-15</td>\n",
       "      <td>2015-08-17</td>\n",
       "      <td>Palestinian Ministry of Health Maternal Child ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Pre-exposure Prophylaxis (PrEP) for People Who...</td>\n",
       "      <td>1</td>\n",
       "      <td>People who inject drugs (PWID) experience high...</td>\n",
       "      <td>0</td>\n",
       "      <td>Intravenous Drug Abuse</td>\n",
       "      <td>behavioral: prep uptake/adherence intervention...</td>\n",
       "      <td>PrEP uptake by self-report, measured using 1 i...</td>\n",
       "      <td>Participant satisfaction with intervention con...</td>\n",
       "      <td>Boston University</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA)</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2021-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2019-03-11</td>\n",
       "      <td>2021-03-10</td>\n",
       "      <td>unknown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Tailored Inhibitory Control Training to Revers...</td>\n",
       "      <td>0</td>\n",
       "      <td>Insufficient inhibitory control is one pathway...</td>\n",
       "      <td>0</td>\n",
       "      <td>Smoking|Alcohol Drinking|Prescription Drug Abu...</td>\n",
       "      <td>behavioral: person-centered inhibitory control...</td>\n",
       "      <td>Inhibitory control performance, Task 1, Perfor...</td>\n",
       "      <td>Far transfer to a task related to inhibitory c...</td>\n",
       "      <td>University of Oregon</td>\n",
       "      <td>none</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>103</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2014-09</td>\n",
       "      <td>2016-04</td>\n",
       "      <td>2016-05</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>University of Oregon, Social and Affective Neu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Neuromodulation of Trauma Memories in PTSD &amp; A...</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to examine the ef...</td>\n",
       "      <td>1</td>\n",
       "      <td>Alcohol Dependence|PTSD</td>\n",
       "      <td>drug: propranolol|drug: placebo</td>\n",
       "      <td>Retrieval Session Distress Scores (Session 1),...</td>\n",
       "      <td>Proportion of Drinking Days, Proportion of dri...</td>\n",
       "      <td>Medical University of South Carolina</td>\n",
       "      <td>National Institute on Alcohol Abuse and Alcoho...</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>44</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2010-01</td>\n",
       "      <td>2012-08</td>\n",
       "      <td>2012-08</td>\n",
       "      <td>2010-01-25</td>\n",
       "      <td>2016-03-08</td>\n",
       "      <td>MUSC, Charleston, South Carolina, 294258908, U...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                         Study Title  Study Status  \\\n",
       "0  Effectiveness of a Problem-solving Interventio...             0   \n",
       "1  Investigating the Effect of a Prenatal Family ...             0   \n",
       "2  Pre-exposure Prophylaxis (PrEP) for People Who...             1   \n",
       "3  Tailored Inhibitory Control Training to Revers...             0   \n",
       "4  Neuromodulation of Trauma Memories in PTSD & A...             0   \n",
       "\n",
       "                                       Brief Summary  Study Results  \\\n",
       "0  We will conduct a two-arm individually randomi...              0   \n",
       "1  The purpose of this study is to measure the di...              0   \n",
       "2  People who inject drugs (PWID) experience high...              0   \n",
       "3  Insufficient inhibitory control is one pathway...              0   \n",
       "4  The purpose of this study is to examine the ef...              1   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0  Mental Health Issue (E.G., Depression, Psychos...   \n",
       "1  Focus: Contraceptive Counseling|Focus: Postpar...   \n",
       "2                             Intravenous Drug Abuse   \n",
       "3  Smoking|Alcohol Drinking|Prescription Drug Abu...   \n",
       "4                            Alcohol Dependence|PTSD   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  behavioral: pride 'step 1' problem-solving int...   \n",
       "1  other: family planning counseling let by commu...   \n",
       "2  behavioral: prep uptake/adherence intervention...   \n",
       "3  behavioral: person-centered inhibitory control...   \n",
       "4                    drug: propranolol|drug: placebo   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Mental health symptoms, The Strengths and Diff...   \n",
       "1  Self-reported contraceptive use, 6 months post...   \n",
       "2  PrEP uptake by self-report, measured using 1 i...   \n",
       "3  Inhibitory control performance, Task 1, Perfor...   \n",
       "4  Retrieval Session Distress Scores (Session 1),...   \n",
       "\n",
       "                          Secondary Outcome Measures  \\\n",
       "0  Mental health symptoms, The adolescent-reporte...   \n",
       "1  Intent to use contraception in the future, 6 m...   \n",
       "2  Participant satisfaction with intervention con...   \n",
       "3  Far transfer to a task related to inhibitory c...   \n",
       "4  Proportion of Drinking Days, Proportion of dri...   \n",
       "\n",
       "                                      Sponsor  \\\n",
       "0                                     Sangath   \n",
       "1  Planned Parenthood League of Massachusetts   \n",
       "2                           Boston University   \n",
       "3                        University of Oregon   \n",
       "4        Medical University of South Carolina   \n",
       "\n",
       "                                       Collaborators     Sex  \\\n",
       "0  Harvard Medical School (HMS and HSDM)|London S...     ALL   \n",
       "1          Society for Family Planning Research Fund  FEMALE   \n",
       "2            National Institute on Drug Abuse (NIDA)     ALL   \n",
       "3                                               none     ALL   \n",
       "4  National Institute on Alcohol Abuse and Alcoho...     ALL   \n",
       "\n",
       "                         Age    Phases  Enrollment Funder Type  \\\n",
       "0               CHILD, ADULT  NO PHASE         250       OTHER   \n",
       "1  CHILD, ADULT, OLDER_ADULT  NO PHASE         176       OTHER   \n",
       "2         ADULT, OLDER_ADULT  NO PHASE           0       OTHER   \n",
       "3                      ADULT  NO PHASE         103       OTHER   \n",
       "4         ADULT, OLDER_ADULT    PHASE2          44       OTHER   \n",
       "\n",
       "       Study Type                                       Study Design  \\\n",
       "0  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "1  INTERVENTIONAL  Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
       "2  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "3  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "4  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "\n",
       "   Start Date Primary Completion Date Completion Date First Posted  \\\n",
       "0  2018-08-20              2019-01-20      2019-02-28   2018-08-14   \n",
       "1     2013-08                 2014-12         2014-12   2013-05-15   \n",
       "2     2021-03                 2022-03         2022-03   2019-03-11   \n",
       "3     2014-09                 2016-04         2016-05   2016-10-26   \n",
       "4     2010-01                 2012-08         2012-08   2010-01-25   \n",
       "\n",
       "  Last Update Posted                                          Locations  \n",
       "0         2019-05-21           Sangath, New Delhi, Delhi, 110016, India  \n",
       "1         2015-08-17  Palestinian Ministry of Health Maternal Child ...  \n",
       "2         2021-03-10                                            unknown  \n",
       "3         2016-10-26  University of Oregon, Social and Affective Neu...  \n",
       "4         2016-03-08  MUSC, Charleston, South Carolina, 294258908, U...  "
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Sanity check\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5e041de0-44ba-4f92-8238-e5fca7a769c7",
   "metadata": {},
   "source": [
    "Next we will look into the `Sex` column and see if we can turn them into dummy variables."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "e27f8b0d-f630-445e-8119-5b6a354d4ddc",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Sex\n",
       "ALL        260212\n",
       "FEMALE      29436\n",
       "MALE        15105\n",
       "unknown       357\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['Sex'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "393572ea-7b00-4ada-bb2e-5ab0640cfa93",
   "metadata": {},
   "source": [
    "Interesting to note that there are 357 unknowns. \n",
    "- We should be able to group them with 'ALL', because the study would only choose to recruit male or female participants if that was the requirement for their clinical trial.\n",
    "- Then we can turn this column into dummy variables with pd.get_dummies()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "ec236be3-ec43-4d4e-8146-409040e63a03",
   "metadata": {},
   "outputs": [],
   "source": [
    "# replacing `unknown` with `ALL`\n",
    "df['Sex'] = np.where(df['Sex'] == 'unknown', 'ALL', df['Sex'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "4b078eb9-e533-494b-9c02-bb9e6c2d4161",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Sex_ALL</th>\n",
       "      <th>Sex_FEMALE</th>\n",
       "      <th>Sex_MALE</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Effectiveness of a Problem-solving Interventio...</td>\n",
       "      <td>0</td>\n",
       "      <td>We will conduct a two-arm individually randomi...</td>\n",
       "      <td>0</td>\n",
       "      <td>Mental Health Issue (E.G., Depression, Psychos...</td>\n",
       "      <td>behavioral: pride 'step 1' problem-solving int...</td>\n",
       "      <td>Mental health symptoms, The Strengths and Diff...</td>\n",
       "      <td>Mental health symptoms, The adolescent-reporte...</td>\n",
       "      <td>Sangath</td>\n",
       "      <td>Harvard Medical School (HMS and HSDM)|London S...</td>\n",
       "      <td>CHILD, ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>250</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2018-08-20</td>\n",
       "      <td>2019-01-20</td>\n",
       "      <td>2019-02-28</td>\n",
       "      <td>2018-08-14</td>\n",
       "      <td>2019-05-21</td>\n",
       "      <td>Sangath, New Delhi, Delhi, 110016, India</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Investigating the Effect of a Prenatal Family ...</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to measure the di...</td>\n",
       "      <td>0</td>\n",
       "      <td>Focus: Contraceptive Counseling|Focus: Postpar...</td>\n",
       "      <td>other: family planning counseling let by commu...</td>\n",
       "      <td>Self-reported contraceptive use, 6 months post...</td>\n",
       "      <td>Intent to use contraception in the future, 6 m...</td>\n",
       "      <td>Planned Parenthood League of Massachusetts</td>\n",
       "      <td>Society for Family Planning Research Fund</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>176</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2013-08</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2013-05-15</td>\n",
       "      <td>2015-08-17</td>\n",
       "      <td>Palestinian Ministry of Health Maternal Child ...</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Pre-exposure Prophylaxis (PrEP) for People Who...</td>\n",
       "      <td>1</td>\n",
       "      <td>People who inject drugs (PWID) experience high...</td>\n",
       "      <td>0</td>\n",
       "      <td>Intravenous Drug Abuse</td>\n",
       "      <td>behavioral: prep uptake/adherence intervention...</td>\n",
       "      <td>PrEP uptake by self-report, measured using 1 i...</td>\n",
       "      <td>Participant satisfaction with intervention con...</td>\n",
       "      <td>Boston University</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA)</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2021-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2019-03-11</td>\n",
       "      <td>2021-03-10</td>\n",
       "      <td>unknown</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Tailored Inhibitory Control Training to Revers...</td>\n",
       "      <td>0</td>\n",
       "      <td>Insufficient inhibitory control is one pathway...</td>\n",
       "      <td>0</td>\n",
       "      <td>Smoking|Alcohol Drinking|Prescription Drug Abu...</td>\n",
       "      <td>behavioral: person-centered inhibitory control...</td>\n",
       "      <td>Inhibitory control performance, Task 1, Perfor...</td>\n",
       "      <td>Far transfer to a task related to inhibitory c...</td>\n",
       "      <td>University of Oregon</td>\n",
       "      <td>none</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>103</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2014-09</td>\n",
       "      <td>2016-04</td>\n",
       "      <td>2016-05</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>University of Oregon, Social and Affective Neu...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Neuromodulation of Trauma Memories in PTSD &amp; A...</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to examine the ef...</td>\n",
       "      <td>1</td>\n",
       "      <td>Alcohol Dependence|PTSD</td>\n",
       "      <td>drug: propranolol|drug: placebo</td>\n",
       "      <td>Retrieval Session Distress Scores (Session 1),...</td>\n",
       "      <td>Proportion of Drinking Days, Proportion of dri...</td>\n",
       "      <td>Medical University of South Carolina</td>\n",
       "      <td>National Institute on Alcohol Abuse and Alcoho...</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>44</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2010-01</td>\n",
       "      <td>2012-08</td>\n",
       "      <td>2012-08</td>\n",
       "      <td>2010-01-25</td>\n",
       "      <td>2016-03-08</td>\n",
       "      <td>MUSC, Charleston, South Carolina, 294258908, U...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                         Study Title  Study Status  \\\n",
       "0  Effectiveness of a Problem-solving Interventio...             0   \n",
       "1  Investigating the Effect of a Prenatal Family ...             0   \n",
       "2  Pre-exposure Prophylaxis (PrEP) for People Who...             1   \n",
       "3  Tailored Inhibitory Control Training to Revers...             0   \n",
       "4  Neuromodulation of Trauma Memories in PTSD & A...             0   \n",
       "\n",
       "                                       Brief Summary  Study Results  \\\n",
       "0  We will conduct a two-arm individually randomi...              0   \n",
       "1  The purpose of this study is to measure the di...              0   \n",
       "2  People who inject drugs (PWID) experience high...              0   \n",
       "3  Insufficient inhibitory control is one pathway...              0   \n",
       "4  The purpose of this study is to examine the ef...              1   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0  Mental Health Issue (E.G., Depression, Psychos...   \n",
       "1  Focus: Contraceptive Counseling|Focus: Postpar...   \n",
       "2                             Intravenous Drug Abuse   \n",
       "3  Smoking|Alcohol Drinking|Prescription Drug Abu...   \n",
       "4                            Alcohol Dependence|PTSD   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  behavioral: pride 'step 1' problem-solving int...   \n",
       "1  other: family planning counseling let by commu...   \n",
       "2  behavioral: prep uptake/adherence intervention...   \n",
       "3  behavioral: person-centered inhibitory control...   \n",
       "4                    drug: propranolol|drug: placebo   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Mental health symptoms, The Strengths and Diff...   \n",
       "1  Self-reported contraceptive use, 6 months post...   \n",
       "2  PrEP uptake by self-report, measured using 1 i...   \n",
       "3  Inhibitory control performance, Task 1, Perfor...   \n",
       "4  Retrieval Session Distress Scores (Session 1),...   \n",
       "\n",
       "                          Secondary Outcome Measures  \\\n",
       "0  Mental health symptoms, The adolescent-reporte...   \n",
       "1  Intent to use contraception in the future, 6 m...   \n",
       "2  Participant satisfaction with intervention con...   \n",
       "3  Far transfer to a task related to inhibitory c...   \n",
       "4  Proportion of Drinking Days, Proportion of dri...   \n",
       "\n",
       "                                      Sponsor  \\\n",
       "0                                     Sangath   \n",
       "1  Planned Parenthood League of Massachusetts   \n",
       "2                           Boston University   \n",
       "3                        University of Oregon   \n",
       "4        Medical University of South Carolina   \n",
       "\n",
       "                                       Collaborators  \\\n",
       "0  Harvard Medical School (HMS and HSDM)|London S...   \n",
       "1          Society for Family Planning Research Fund   \n",
       "2            National Institute on Drug Abuse (NIDA)   \n",
       "3                                               none   \n",
       "4  National Institute on Alcohol Abuse and Alcoho...   \n",
       "\n",
       "                         Age    Phases  Enrollment Funder Type  \\\n",
       "0               CHILD, ADULT  NO PHASE         250       OTHER   \n",
       "1  CHILD, ADULT, OLDER_ADULT  NO PHASE         176       OTHER   \n",
       "2         ADULT, OLDER_ADULT  NO PHASE           0       OTHER   \n",
       "3                      ADULT  NO PHASE         103       OTHER   \n",
       "4         ADULT, OLDER_ADULT    PHASE2          44       OTHER   \n",
       "\n",
       "       Study Type                                       Study Design  \\\n",
       "0  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "1  INTERVENTIONAL  Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
       "2  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "3  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "4  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "\n",
       "   Start Date Primary Completion Date Completion Date First Posted  \\\n",
       "0  2018-08-20              2019-01-20      2019-02-28   2018-08-14   \n",
       "1     2013-08                 2014-12         2014-12   2013-05-15   \n",
       "2     2021-03                 2022-03         2022-03   2019-03-11   \n",
       "3     2014-09                 2016-04         2016-05   2016-10-26   \n",
       "4     2010-01                 2012-08         2012-08   2010-01-25   \n",
       "\n",
       "  Last Update Posted                                          Locations  \\\n",
       "0         2019-05-21           Sangath, New Delhi, Delhi, 110016, India   \n",
       "1         2015-08-17  Palestinian Ministry of Health Maternal Child ...   \n",
       "2         2021-03-10                                            unknown   \n",
       "3         2016-10-26  University of Oregon, Social and Affective Neu...   \n",
       "4         2016-03-08  MUSC, Charleston, South Carolina, 294258908, U...   \n",
       "\n",
       "   Sex_ALL  Sex_FEMALE  Sex_MALE  \n",
       "0        1           0         0  \n",
       "1        0           1         0  \n",
       "2        1           0         0  \n",
       "3        1           0         0  \n",
       "4        1           0         0  "
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Creating dummy variables with prefix\n",
    "sex_dummy = pd.get_dummies(df['Sex'], prefix='Sex', dtype=int)\n",
    "\n",
    "# Concatenate dummies to df and drop Sex column\n",
    "df = pd.concat([df, sex_dummy], axis = 1)\n",
    "df.drop(columns = 'Sex', inplace = True)\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "06397d8d-f3c1-478f-88a1-39e46cbc9412",
   "metadata": {},
   "source": [
    "This looks very good. Now we will move onto the `Age` column and try to break it down further for modelling."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "9cd67b22-6c18-4134-ad7a-ef7a3d6a5915",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Age\n",
       "ADULT, OLDER_ADULT           194578\n",
       "ADULT                         45937\n",
       "CHILD, ADULT, OLDER_ADULT     28746\n",
       "CHILD                         19260\n",
       "CHILD, ADULT                  12144\n",
       "OLDER_ADULT                    4445\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['Age'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f45cdcb5-f9de-483f-989b-c27dbe3e8cd2",
   "metadata": {},
   "source": [
    "We can notice that one study can have multiple age groups. The most popular age group are studies that have both `ADULT` and `OLDER_ADULT` participants.\n",
    "- We can use str.get_dummies() to separate the groups and essentially turn them into dummy variables."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "d216390a-fcf5-4317-9acb-46b73db5eb07",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Sex_ALL</th>\n",
       "      <th>Sex_FEMALE</th>\n",
       "      <th>Sex_MALE</th>\n",
       "      <th>Age_ADULT</th>\n",
       "      <th>Age_CHILD</th>\n",
       "      <th>Age_OLDER_ADULT</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Effectiveness of a Problem-solving Interventio...</td>\n",
       "      <td>0</td>\n",
       "      <td>We will conduct a two-arm individually randomi...</td>\n",
       "      <td>0</td>\n",
       "      <td>Mental Health Issue (E.G., Depression, Psychos...</td>\n",
       "      <td>behavioral: pride 'step 1' problem-solving int...</td>\n",
       "      <td>Mental health symptoms, The Strengths and Diff...</td>\n",
       "      <td>Mental health symptoms, The adolescent-reporte...</td>\n",
       "      <td>Sangath</td>\n",
       "      <td>Harvard Medical School (HMS and HSDM)|London S...</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>250</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2018-08-20</td>\n",
       "      <td>2019-01-20</td>\n",
       "      <td>2019-02-28</td>\n",
       "      <td>2018-08-14</td>\n",
       "      <td>2019-05-21</td>\n",
       "      <td>Sangath, New Delhi, Delhi, 110016, India</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Investigating the Effect of a Prenatal Family ...</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to measure the di...</td>\n",
       "      <td>0</td>\n",
       "      <td>Focus: Contraceptive Counseling|Focus: Postpar...</td>\n",
       "      <td>other: family planning counseling let by commu...</td>\n",
       "      <td>Self-reported contraceptive use, 6 months post...</td>\n",
       "      <td>Intent to use contraception in the future, 6 m...</td>\n",
       "      <td>Planned Parenthood League of Massachusetts</td>\n",
       "      <td>Society for Family Planning Research Fund</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>176</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2013-08</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2014-12</td>\n",
       "      <td>2013-05-15</td>\n",
       "      <td>2015-08-17</td>\n",
       "      <td>Palestinian Ministry of Health Maternal Child ...</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Pre-exposure Prophylaxis (PrEP) for People Who...</td>\n",
       "      <td>1</td>\n",
       "      <td>People who inject drugs (PWID) experience high...</td>\n",
       "      <td>0</td>\n",
       "      <td>Intravenous Drug Abuse</td>\n",
       "      <td>behavioral: prep uptake/adherence intervention...</td>\n",
       "      <td>PrEP uptake by self-report, measured using 1 i...</td>\n",
       "      <td>Participant satisfaction with intervention con...</td>\n",
       "      <td>Boston University</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA)</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>0</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2021-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2022-03</td>\n",
       "      <td>2019-03-11</td>\n",
       "      <td>2021-03-10</td>\n",
       "      <td>unknown</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Tailored Inhibitory Control Training to Revers...</td>\n",
       "      <td>0</td>\n",
       "      <td>Insufficient inhibitory control is one pathway...</td>\n",
       "      <td>0</td>\n",
       "      <td>Smoking|Alcohol Drinking|Prescription Drug Abu...</td>\n",
       "      <td>behavioral: person-centered inhibitory control...</td>\n",
       "      <td>Inhibitory control performance, Task 1, Perfor...</td>\n",
       "      <td>Far transfer to a task related to inhibitory c...</td>\n",
       "      <td>University of Oregon</td>\n",
       "      <td>none</td>\n",
       "      <td>NO PHASE</td>\n",
       "      <td>103</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2014-09</td>\n",
       "      <td>2016-04</td>\n",
       "      <td>2016-05</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>2016-10-26</td>\n",
       "      <td>University of Oregon, Social and Affective Neu...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Neuromodulation of Trauma Memories in PTSD &amp; A...</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to examine the ef...</td>\n",
       "      <td>1</td>\n",
       "      <td>Alcohol Dependence|PTSD</td>\n",
       "      <td>drug: propranolol|drug: placebo</td>\n",
       "      <td>Retrieval Session Distress Scores (Session 1),...</td>\n",
       "      <td>Proportion of Drinking Days, Proportion of dri...</td>\n",
       "      <td>Medical University of South Carolina</td>\n",
       "      <td>National Institute on Alcohol Abuse and Alcoho...</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>44</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2010-01</td>\n",
       "      <td>2012-08</td>\n",
       "      <td>2012-08</td>\n",
       "      <td>2010-01-25</td>\n",
       "      <td>2016-03-08</td>\n",
       "      <td>MUSC, Charleston, South Carolina, 294258908, U...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                         Study Title  Study Status  \\\n",
       "0  Effectiveness of a Problem-solving Interventio...             0   \n",
       "1  Investigating the Effect of a Prenatal Family ...             0   \n",
       "2  Pre-exposure Prophylaxis (PrEP) for People Who...             1   \n",
       "3  Tailored Inhibitory Control Training to Revers...             0   \n",
       "4  Neuromodulation of Trauma Memories in PTSD & A...             0   \n",
       "\n",
       "                                       Brief Summary  Study Results  \\\n",
       "0  We will conduct a two-arm individually randomi...              0   \n",
       "1  The purpose of this study is to measure the di...              0   \n",
       "2  People who inject drugs (PWID) experience high...              0   \n",
       "3  Insufficient inhibitory control is one pathway...              0   \n",
       "4  The purpose of this study is to examine the ef...              1   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0  Mental Health Issue (E.G., Depression, Psychos...   \n",
       "1  Focus: Contraceptive Counseling|Focus: Postpar...   \n",
       "2                             Intravenous Drug Abuse   \n",
       "3  Smoking|Alcohol Drinking|Prescription Drug Abu...   \n",
       "4                            Alcohol Dependence|PTSD   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  behavioral: pride 'step 1' problem-solving int...   \n",
       "1  other: family planning counseling let by commu...   \n",
       "2  behavioral: prep uptake/adherence intervention...   \n",
       "3  behavioral: person-centered inhibitory control...   \n",
       "4                    drug: propranolol|drug: placebo   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Mental health symptoms, The Strengths and Diff...   \n",
       "1  Self-reported contraceptive use, 6 months post...   \n",
       "2  PrEP uptake by self-report, measured using 1 i...   \n",
       "3  Inhibitory control performance, Task 1, Perfor...   \n",
       "4  Retrieval Session Distress Scores (Session 1),...   \n",
       "\n",
       "                          Secondary Outcome Measures  \\\n",
       "0  Mental health symptoms, The adolescent-reporte...   \n",
       "1  Intent to use contraception in the future, 6 m...   \n",
       "2  Participant satisfaction with intervention con...   \n",
       "3  Far transfer to a task related to inhibitory c...   \n",
       "4  Proportion of Drinking Days, Proportion of dri...   \n",
       "\n",
       "                                      Sponsor  \\\n",
       "0                                     Sangath   \n",
       "1  Planned Parenthood League of Massachusetts   \n",
       "2                           Boston University   \n",
       "3                        University of Oregon   \n",
       "4        Medical University of South Carolina   \n",
       "\n",
       "                                       Collaborators    Phases  Enrollment  \\\n",
       "0  Harvard Medical School (HMS and HSDM)|London S...  NO PHASE         250   \n",
       "1          Society for Family Planning Research Fund  NO PHASE         176   \n",
       "2            National Institute on Drug Abuse (NIDA)  NO PHASE           0   \n",
       "3                                               none  NO PHASE         103   \n",
       "4  National Institute on Alcohol Abuse and Alcoho...    PHASE2          44   \n",
       "\n",
       "  Funder Type      Study Type  \\\n",
       "0       OTHER  INTERVENTIONAL   \n",
       "1       OTHER  INTERVENTIONAL   \n",
       "2       OTHER  INTERVENTIONAL   \n",
       "3       OTHER  INTERVENTIONAL   \n",
       "4       OTHER  INTERVENTIONAL   \n",
       "\n",
       "                                        Study Design  Start Date  \\\n",
       "0  Allocation: RANDOMIZED|Intervention Model: PAR...  2018-08-20   \n",
       "1  Allocation: NON_RANDOMIZED|Intervention Model:...     2013-08   \n",
       "2  Allocation: RANDOMIZED|Intervention Model: PAR...     2021-03   \n",
       "3  Allocation: RANDOMIZED|Intervention Model: PAR...     2014-09   \n",
       "4  Allocation: RANDOMIZED|Intervention Model: PAR...     2010-01   \n",
       "\n",
       "  Primary Completion Date Completion Date First Posted Last Update Posted  \\\n",
       "0              2019-01-20      2019-02-28   2018-08-14         2019-05-21   \n",
       "1                 2014-12         2014-12   2013-05-15         2015-08-17   \n",
       "2                 2022-03         2022-03   2019-03-11         2021-03-10   \n",
       "3                 2016-04         2016-05   2016-10-26         2016-10-26   \n",
       "4                 2012-08         2012-08   2010-01-25         2016-03-08   \n",
       "\n",
       "                                           Locations  Sex_ALL  Sex_FEMALE  \\\n",
       "0           Sangath, New Delhi, Delhi, 110016, India        1           0   \n",
       "1  Palestinian Ministry of Health Maternal Child ...        0           1   \n",
       "2                                            unknown        1           0   \n",
       "3  University of Oregon, Social and Affective Neu...        1           0   \n",
       "4  MUSC, Charleston, South Carolina, 294258908, U...        1           0   \n",
       "\n",
       "   Sex_MALE  Age_ADULT  Age_CHILD  Age_OLDER_ADULT  \n",
       "0         0          1          1                0  \n",
       "1         0          1          1                1  \n",
       "2         0          1          0                1  \n",
       "3         0          1          0                0  \n",
       "4         0          1          0                1  "
      ]
     },
     "execution_count": 47,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Creating dummy variables with prefix\n",
    "age_dummy = df['Age'].str.get_dummies(sep=', ').add_prefix('Age_')\n",
    "\n",
    "# Concatenate dummies to df and drop Age column\n",
    "df = pd.concat([df, age_dummy], axis = 1)\n",
    "df.drop(columns = 'Age', inplace = True)\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "65f008d3-45b7-4a08-8c37-1a994eb04370",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "1e20b50a-22ff-4f6a-af24-e347c7343033",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "30b2e239-f89b-47cb-87b4-c16ecbd8fce6",
   "metadata": {},
   "outputs": [],
   "source": [
    "df.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "726b6404-ad8b-4c45-a7d9-84d5b077f766",
   "metadata": {},
   "outputs": [],
   "source": [
    "df['Study Results'].value_counts()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Clinical_Trials_env",
   "language": "python",
   "name": "clinical_trials_env"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
